###begin article-title 0
###xml 65 74 <span type="species:ncbi:7955">zebrafish</span>
O-GlcNAc modifications regulate cell survival and epiboly during zebrafish development
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 68 69 65 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 467 471 464 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 722 726 719 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 330 334 <span type="species:ncbi:10090">mice</span>
###xml 503 508 <span type="species:ncbi:10090">mouse</span>
###xml 623 632 <span type="species:ncbi:7955">zebrafish</span>
###xml 704 713 <span type="species:ncbi:7955">Zebrafish</span>
The post-translational addition of the monosaccharide O-linked beta-N-acetylglucosamine (O-GlcNAc) regulates the activity of a wide variety of nuclear and cytoplasmic proteins. The enzymes O-GlcNAc Transferase (Ogt) and O-GlcNAcase (Oga) catalyze, respectively, the attachment and removal of O-GlcNAc to target proteins. In adult mice, Ogt and Oga attenuate the response to insulin by modifying several components of the signal transduction pathway. Complete loss of ogt function, however, is lethal to mouse embryonic stem cells, suggesting that the enzyme has additional, unstudied roles in development. We have utilized zebrafish as a model to determine role of O-GlcNAc modifications in development. Zebrafish has two ogt genes, encoding six different enzymatic isoforms that are expressed maternally and zygotically.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 80 83 80 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt</italic>
###xml 91 95 91 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">oga </italic>
###xml 131 135 131 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 857 875 857 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spiel ohne grenzen</italic>
###xml 34 43 <span type="species:ncbi:7955">zebrafish</span>
###xml 70 79 <span type="species:ncbi:7955">zebrafish</span>
###xml 85 90 <span type="species:ncbi:9606">human</span>
###xml 938 943 <span type="species:ncbi:9606">human</span>
We manipulated O-GlcNAc levels in zebrafish embryos by overexpressing zebrafish ogt, human oga or by injecting morpholinos against ogt transcripts. Each of these treatments results in embryos with shortened body axes and reduced brains at 24 hpf. The embryos had 23% fewer cells than controls, and displayed increased rates of cell death as early as the mid-gastrula stages. An extensive marker analysis indicates that derivatives of three germ layers are reduced to variable extents, and the embryos are severely disorganized after gastrulation. Overexpression of Ogt and Oga delayed epiboly and caused a severe disorganization of the microtubule and actin based cytoskeleton in the extra-embryonic yolk syncytial layer (YSL). The cytoskeletal defects resemble those previously reported for embryos lacking function of the Pou5f1/Oct4 transcription factor spiel ohne grenzen. Consistent with this, Pou5f1/Oct4 is modified by O-GlcNAc in human embryonic stem cells.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
We conclude that O-GlcNAc modifications control the activity of proteins that regulate apoptosis and epiboly movements, but do not seem to regulate germ layer specification. O-GlcNAc modifies the transcription factor Spiel ohne grenzen/Pou5f1 and may regulate its activity.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 468 469 465 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 795 796 789 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 797 798 791 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 947 948 941 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 949 951 943 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1094 1095 1088 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1096 1097 1090 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1098 1100 1092 1094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1101 1103 1095 1097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1235 1237 1229 1231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1238 1240 1232 1234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1401 1403 1395 1397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
The activities of key proteins must be controlled in a precise spatio-temporal manner for proper embryonic development. This is accomplished by regulation at the transcriptional, translational and post-translational levels. While the effects of post-translational modifications such as phosphorylation, proteolytic cleavage and N-linked glycosylation have been well studied, relatively little is known about how the O-linked addition of the simple monosaccharide beta-N-acetylglucosamine (O-GlcNAc) affects protein activities during development. This sugar is attached to a wide variety of nuclear and cytoplasmic proteins, including those implicated in controlling important steps during development such as NeuroD1, beta-catenin, c-myc and the cytoplasmic tails of plakoglobin and E-cadherin [1-5]. Other proteins modified by O-GlcNAc include casein kinase II (CKII), nuclear pore proteins, RNA polymerase II and numerous transcription factors [6-15]. These observations implicate O-GlcNAc in the regulation of transcription, protein stability and cell cycle progression, among other events [7,8,16,17]. Attachment of O-GlcNAc is rapidly induced in response to external stimuli such as nutrient status and stress, and is reversible [18,19]. Thus, unlike complex glycosylation, O-GlcNAc modification is highly dynamic and transiently alters protein function in a manner analogous to phosphorylation [20].
###end p 9
###begin p 10
###xml 227 229 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 340 342 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 584 586 584 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 587 589 587 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 907 909 907 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1005 1007 1005 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1133 1135 1133 1135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1319 1321 1319 1321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1322 1324 1322 1324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1452 1454 1452 1454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1455 1457 1455 1457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1458 1460 1458 1460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 1355 1359 <span type="species:ncbi:10090">mice</span>
O-GlcNAc is covalently linked to serine and threonine residues of target proteins by the enzyme O-GlcNAc Transferase (Ogt), which uses the product of the hexosamine biosynthetic pathway, UDP-GlcNAc, as a high-energy substrate [21,22]. The reverse reaction is catalyzed by O-GlcNAcase (Oga), a cytosolic and nuclear N-acetylglucosaminidase [23,24]. Both Ogt and Oga are modified by O-GlcNAc. The residues of many proteins modified by O-GlcNAc are also targets of ser/thr kinases, suggesting that Ogt modulates signal transduction pathways by preventing phosphorylation kinase targets [20,25]. This model of regulatory control by O-GlcNAc modification is supported by studies of the roles of Ogt and Oga in the insulin pathway. Insulin shuts down glucose production in hepatocytes by promoting the phosphorylation of the CRTC2 transcription factor, which is then targeted for ubiquitin-dependent degradation [26]. By O-GlcNAcylating CRTC2, Ogt prevents its phosphorylation and protects it from degradation [27]. CRTC2 then antagonizes the effects of insulin by inducing expression of gluconeogenic genes such as glucose-6-phosphatase [28]. Ogt also antagonizes the response to insulin in adipocytes by modifying and inactivating a number of components of the insulin signal transduction cascade, including IRSs and PI3K [29,30]. When overexpressed in adult mice, Ogt induces insulin resistance whereas Oga suppresses the development of type II diabetes [27,29,31].
###end p 10
###begin p 11
###xml 20 24 20 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 64 66 64 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 424 426 424 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 427 429 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 494 503 494 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 565 567 565 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 628 635 628 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 713 721 713 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 730 732 730 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 843 845 843 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 3 9 <span type="species:ncbi:9606">humans</span>
In humans, a single ogt gene produces three enzymatic isoforms [32]. Two isoforms are localized to the nuclei and cytoplasm, while one isoform appears to be localized exclusively to the mitochondria [33]. Ogt contains two conserved catalytic domains in the C-terminus, called CDI and CDII, and an N-terminal tetratricopeptide repeat domain (TPR) that differs in the three isoforms and mediates protein-protein interactions [34,35]. Although the monomer can catalyze the addition of O-GlcNAc in in vitro assays, multimeric Ogt has a greater affinity for UDP-GlcNAc [34]. This suggests that Ogt forms an active multimeric complex in vivo. In support of this idea, the TPR domain is essential for enzyme activity in Xenopus oocytes [36]. The recent solving of a bacterial Ogt homolog has shed light on the activity and specificity of the enzyme [37].
###end p 11
###begin p 12
###xml 117 121 117 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 193 195 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 222 226 222 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 395 399 395 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 456 458 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 510 514 510 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 662 666 662 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 717 725 717 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 850 852 850 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 957 959 957 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 960 962 960 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 989 993 989 993 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 1157 1161 1157 1161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 111 115 <span type="species:ncbi:10090">mice</span>
###xml 248 253 <span type="species:ncbi:10090">mouse</span>
The role of O-GlcNAc modification in regulating embryonic development has been more difficult to establish. In mice, ogt is expressed in embryonic stem cells and in all adult tissues examined [38]. The complete absence of ogt function is lethal to mouse embryonic stem cells and embryos, but the phenotype has not been well characterized [38]. Experiments with conditional alleles revealed that ogt is required in a tissue specific manner at later stages [39]. Differentiated neurons survive in the absence of ogt function, but the brains are reduced and animals survive less than 10 days. By contrast, embryonic fibroblasts do not proliferate in the absence of ogt function, and mutant T-cells undergo apoptosis. In Xenopus oocytes, O-GlcNAc levels fluctuate during oogenesis and remain elevated after fertilization until the onset of gastrulation [36]. Ogt activity is required for oocyte maturation and blocking its activity prevents entry into M-phase [36,40]. These results show that ogt is required for cell proliferation at early stages, but has stage and tissue dependent functions at later stages. We were interested in determining the function of ogt during the blastula and gastrula stages, when the body axes are established and the germ layers form.
###end p 12
###begin p 13
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 188 209 188 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arabidopsis thaliana </italic>
###xml 260 264 260 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 331 342 331 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arabidopsis</italic>
###xml 351 359 351 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spindly </italic>
###xml 360 363 360 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spy</italic>
###xml 369 382 369 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">secret agent </italic>
###xml 383 386 383 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sec</italic>
###xml 389 391 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 394 403 394 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spy; sec </italic>
###xml 524 526 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 554 558 554 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 647 651 647 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spy </italic>
###xml 768 772 768 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spy </italic>
###xml 857 859 857 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 860 862 860 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 188 208 <span type="species:ncbi:3702">Arabidopsis thaliana</span>
ogt is highly conserved throughout evolution, and orthologues are found in at least three eukaryotic kingdoms, including animalia, plantae, and fungi [41,42]. Genetic studies in the plant Arabidopsis thaliana show that it is possible to identify new roles for ogt by analyzing hypomorphic mutant conditions. There are two genes in Arabidopsis, called spindly (spy) and secret agent (sec) [42]. spy; sec double mutant seeds fail to germinate, indicating that the two genes have overlapping requirements in early development [43]. Thus, the requirement of ogt for proliferation in early embryos has been strongly conserved in plants and animals. In spy single mutants, SEC provides sufficient Ogt activity to bypass the early requirement, revealing a later requirement. spy mutant plants display an aberrant response to the plant growth hormone, gibberellin [44,45]. Therefore in plants, Ogt acts at later stages of development to regulate specific signalling pathways, analogous its role modulating the response to insulin in mammals.
###end p 13
###begin p 14
###xml 157 161 157 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 436 439 436 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt</italic>
###xml 482 484 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 551 560 551 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 564 571 564 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 606 608 606 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 795 799 795 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 117 126 <span type="species:ncbi:7955">zebrafish</span>
###xml 176 185 <span type="species:ncbi:7955">zebrafish</span>
###xml 426 435 <span type="species:ncbi:7955">zebrafish</span>
###xml 746 755 <span type="species:ncbi:7955">zebrafish</span>
###xml 761 766 <span type="species:ncbi:9606">human</span>
###xml 1166 1171 <span type="species:ncbi:9606">human</span>
To determine if O-GlcNAc modification modulates signalling pathways that control vertebrate development, we used the zebrafish model organism. There are two ogt orthologues in zebrafish, present in tandem copies on chromosome 14, separated by approximately 200 kb [46]. The two genes are highly similar at the nucleic acid level, and are expressed maternally and zygotically. The genes have two alternatively spliced exons in zebrafish ogt, producing six different enzyme isoforms [46]. We show that both full-length and short Ogt isoforms are active in vitro and in vivo, in contrast to previous reports [46]. To determine the role of O-GlcNAc modifications in development, we increased or decreased O-GlcNAc levels in embryos by overexpressing zebrafish Ogt, human Oga, or morpholinos against ogt transcripts. Each treatment results in smaller embryos with increased rates of cell death. In addition, Ogt and Oga overexpressing embryos have morphogenesis defects, probably resulting from underlying defects in the actin and microtubule based cytoskeleton in the yolk. Finally, we show that the pou class transcription factor Oct4/Pou5f1 is modified by O-GlcNAc in human embryonic stem cells. This suggests that O-GlcNAc regulates the activity of Pou5f1 in embryonic stem cells and, possibly, in whole embryos. We conclude that O-GlcNAc modifications play a critical role during embryogenesis in regulating morphogenesis and cell survival.
###end p 14
###begin title 15
Results
###end title 15
###begin title 16
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 27 36 <span type="species:ncbi:7955">zebrafish</span>
Two ogt genes arose from a zebrafish specific gene duplication
###end title 16
###begin p 17
###xml 41 45 41 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 248 253 248 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogta </italic>
###xml 257 261 257 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogtb</italic>
###xml 282 284 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 311 316 311 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogta </italic>
###xml 388 393 388 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogtb </italic>
###xml 438 440 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 453 474 453 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arabidopsis thaliana </italic>
###xml 516 520 516 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 527 535 527 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spindly </italic>
###xml 536 539 536 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spy</italic>
###xml 545 558 545 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink">secret agent </italic>
###xml 559 562 559 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sec</italic>
###xml 565 567 565 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 657 674 657 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Danio rerio ogta </italic>
###xml 694 698 694 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sec </italic>
###xml 748 751 748 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spy</italic>
###xml 764 781 764 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Danio rerio ogtb </italic>
###xml 801 804 801 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sec</italic>
###xml 832 835 832 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spy</italic>
###xml 911 915 911 915 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sec </italic>
###xml 923 926 923 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spy</italic>
###xml 948 965 948 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Danio rerio ogta </italic>
###xml 969 974 969 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogtb </italic>
###xml 1036 1038 1036 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 1077 1081 1077 1081 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 1125 1129 1125 1129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 1234 1236 1234 1236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1237 1239 1237 1239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1240 1242 1240 1242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 1243 1245 1243 1245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 1283 1287 1283 1287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 1336 1340 1336 1340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 1431 1433 1431 1433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 1436 1438 1436 1438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 1515 1519 1515 1519 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 1562 1584 1562 1584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tetraodon nigroviridis</italic>
###xml 1604 1621 1604 1621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Takifugu rubripes</italic>
###xml 1637 1660 1637 1660 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gasterosteaus aculeatus</italic>
###xml 1674 1689 1674 1689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Oryzias latipes</italic>
###xml 1715 1719 1715 1719 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 1736 1738 1736 1738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 1741 1743 1741 1743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 1744 1746 1744 1746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 1770 1784 1770 1784 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D. rerio ogta </italic>
###xml 1788 1793 1788 1793 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogtb </italic>
###xml 22 31 <span type="species:ncbi:7955">zebrafish</span>
###xml 202 211 <span type="species:ncbi:7955">zebrafish</span>
###xml 453 473 <span type="species:ncbi:3702">Arabidopsis thaliana</span>
###xml 657 668 <span type="species:ncbi:7955">Danio rerio</span>
###xml 764 775 <span type="species:ncbi:7955">Danio rerio</span>
###xml 848 857 <span type="species:ncbi:7955">zebrafish</span>
###xml 948 959 <span type="species:ncbi:7955">Danio rerio</span>
###xml 1217 1221 <span type="species:ncbi:10090">mice</span>
###xml 1226 1232 <span type="species:ncbi:9606">humans</span>
###xml 1326 1335 <span type="species:ncbi:7955">zebrafish</span>
###xml 1498 1510 <span type="species:ncbi:70862">teleost fish</span>
###xml 1562 1584 <span type="species:ncbi:99883">Tetraodon nigroviridis</span>
###xml 1604 1621 <span type="species:ncbi:31033">Takifugu rubripes</span>
###xml 1666 1672 <span type="species:ncbi:8090">medaka</span>
###xml 1674 1689 <span type="species:ncbi:8090">Oryzias latipes</span>
###xml 1770 1778 <span type="species:ncbi:7955">D. rerio</span>
###xml 1819 1828 <span type="species:ncbi:7955">zebrafish</span>
Unlike other animals, zebrafish have two ogt genes, called copy I and copy II, which are 67% identical at the nucleotide level and 89% identical at the amino acid level [46]. To conform to the standard zebrafish nomenclature, we rename these genes ogta and ogtb, respectively (Fig. 1A). Alternative splicing of ogta produces four transcripts (variants 1-4), while alternative splicing of ogtb produces two transcripts (variants 5 and 6) [46]. The plant Arabidopsis thaliana is the only other model organism with two ogt genes, spindly (spy) and secret agent (sec) [42]. We performed a phylogenetic analysis to determine when the duplication event occurred. Danio rerio ogta is 37% identical to sec at the amino acid level and only 21% identical to spy. Similarly, Danio rerio ogtb is 39% identical to sec, and only 22% identical to spy. Thus, both zebrafish genes are more closely related to one another and to sec than to spy. This indicates that Danio rerio ogta and ogtb originated after the plant and animal kingdoms diverged (Fig. 1B). To pinpoint more precisely when the ogt duplication event occurred, we examined the ogt genes in the sequenced genomes of other metazoan animals, including worms, sea squirts, mice and humans [32,38,47,48]. Each of these species has a single ogt gene, raising the possibility that the zebrafish ogt gene duplication occurred during the teleost specific whole genome duplication event (Fig. 1B) [49]. To test this, we examined the sequenced genomes of other teleost fish for ogt orthologues. The green spotted pufferfish (Tetraodon nigroviridis), fugu pufferfish (Takifugu rubripes), stickleback (Gasterosteaus aculeatus) and medaka (Oryzias latipes) each have only a single ogt orthologue (Fig. 1B) [50-52]. We conclude that the D. rerio ogta and ogtb arose from a very recent, zebrafish specific gene duplication.
###end p 17
###begin p 18
###xml 47 51 47 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 0 56 0 56 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The origin and expression pattern of zebrafish <italic>ogt </italic>genes</bold>
###xml 93 98 93 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogta </italic>
###xml 102 107 102 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogtb </italic>
###xml 202 204 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 256 261 256 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogta </italic>
###xml 307 312 307 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogta </italic>
###xml 383 388 383 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogta </italic>
###xml 530 532 530 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 610 614 610 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 793 809 793 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A. thaliana ogt </italic>
###xml 814 818 814 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spy </italic>
###xml 876 880 876 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 988 992 988 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 1077 1081 1077 1081 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 1124 1128 1124 1128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 1308 1312 1308 1312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 1433 1437 1433 1437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 37 46 <span type="species:ncbi:7955">zebrafish</span>
###xml 83 92 <span type="species:ncbi:7955">zebrafish</span>
###xml 793 804 <span type="species:ncbi:3702">A. thaliana</span>
The origin and expression pattern of zebrafish ogt genes. (A) Schematic diagram of zebrafish ogta and ogtb loci (formerly known as copy I and copy II, respectively), which are located on Chromosome 14 [46]. Diagrams of variant 2 and 4 transcripts from the ogta gene are represented under the diagram of the ogta locus. The black box represents the 3' UTR, while the red boxes in the ogta locus and variant 2 transcript represent the alternatively spliced exon 19, which has been proposed to inhibit O-GlcNAc Transferase activity [46]. Exon 19 is absent from variant 4 transcripts. (B) Phylogenetic analysis of ogt genes constructed using the neighbor-joining method using aligned amino acid sequences (see materials and methods for gene identifier numbers for each of the sequences used). The A. thaliana ogt gene spy was used to root the tree, since it is the most divergent ogt gene we analyzed. Bootstrap values for 1,000 repetitions are indicated at the nodes. (C-J) A time course of ogt gene expression from 8-cell (1.25 hpf) (C) to 72 hpf (J) of development reveals that ogt is dynamically expressed in early embryos. ogt is ubiquitously expressed in cleavage stage (C, E), blastula stage (F) and gastrula stage (G) embryos. Signal is not detected in embryos incubated with sense probe (D). At 24 hpf, ogt transcripts are expressed at high levels in the brain and lower levels trunk and tail (H). At 36 hpf (I) and 72 hpf (J), ogt transcripts are restricted to the brain.
###end p 18
###begin p 19
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 75 79 75 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 278 280 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 294 296 294 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 401 403 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 530 532 530 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 535 537 535 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 38 47 <span type="species:ncbi:7955">zebrafish</span>
To investigate the function of ogt in zebrafish, we isolated a full-length ogt transcript from a 15-19 hours post fertilization (hpf) cDNA library. Sequence analysis revealed that this transcript encodes the variant 2 Ogt isoform, which lacks exon 2a and contains exon 19 (Fig. 1A, red boxes) [46]. Since previous experiments showed that bacterially expressed variant 2 Ogt lacked enzymatic activity [46], we removed exon 19 from this construct in order to generate an enzyme with the same sequence as the variant 4 isoform (Fig. 1A) [46].
###end p 19
###begin title 20
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
ogt expression is gradually restricted to the brain
###end title 20
###begin p 21
###xml 123 125 123 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 168 172 168 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 187 195 187 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 246 250 246 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C&#8211;J</xref>
###xml 371 376 371 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogta </italic>
###xml 380 385 380 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogtb </italic>
###xml 463 467 463 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 590 592 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 595 597 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 682 684 682 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 702 706 702 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 773 778 773 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1E, F</xref>
###xml 819 821 819 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1G</xref>
###xml 957 959 957 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1H</xref>
###xml 992 996 992 996 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 1053 1058 1053 1058 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1I, J</xref>
###xml 1084 1088 1084 1088 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
A previous study included an extensive RT-PCR analysis of expression of all Ogt variants over a developmental time course [46]. We examined the spatial distribution of ogt transcripts by in situ hybridization in a developmental time-course (Fig. 1C-J). Our probe was complementary to the entire variant 2 sequence and is expected to hybridize to all transcripts from the ogta and ogtb genes due to the high homology at the nucleotide level between the two genes. ogt transcripts are found in all cells of cleavage stage embryos, consistent with earlier reports of maternal expression (Fig. 1C) [46]. This staining was specific, since no signal was detected with a sense probe (Fig. 1D). High levels of ogt transcripts persist in all cells through the blastula stages (Fig. 1E, F), but decline during gastrulation (Fig. 1G). At 24 hpf, the staining is more intense in neural tissues, especially the brain, than in mesodermal tissues like the notochord (Fig. 1H, arrow). From 36 hpf to 72 hpf, ogt transcripts are localized exclusively in the brain (Fig. 1I, J). This demonstrates that ogt has a more dynamic expression pattern than previously suspected, consistent with the idea that it has different functions at different stages of embryonic development.
###end p 21
###begin title 22
O-GlcNAc modifications regulate embryonic development
###end title 22
###begin p 23
###xml 71 75 71 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 184 188 184 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 255 259 255 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogta</italic>
###xml 319 323 319 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogtb</italic>
###xml 868 870 868 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 1087 1092 1087 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B, C</xref>
###xml 1181 1183 1181 1183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 1323 1327 1323 1327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 1429 1430 1429 1430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
Next, we took a loss-of-function approach to determine the function of ogt during embryonic development. We designed two translation-blocking morpholino oligonucleotides (MOs) against ogt transcripts. MO1 was designed to target all transcript variants of ogta, and MO2 was designed to target all transcript variants of ogtb. Translation blocking MOs inhibit the synthesis of protein from zygotic and maternal transcripts, but do not affect Ogt protein synthesized before the MO is injected. We reasoned that the early expressed protein might provide sufficient Ogt activity to bypass any requirement during the cleavage stages, permitting us to examine the role of Ogt at later stages of development. At 24 hpf, embryos injected with 7.5 ng of a control MO developed normally, and the eyes, midbrain-hindbrain boundary, notochord and somites are clearly visible (Fig. 2A; N = 40). By contrast, more than a third of embryos injected with 7.5 ng MO1 (34%) or MO2 (37%) were smaller than controls, with shortened body axes, reduced heads, small or absent eyes, and twisted notochords (Fig. 2B, C; N = 32, N = 35, respectively). Some embryos showed signs of necrosis in the head (Fig. 2C, arrow), which became more pronounced and more frequent with age (data not shown). When MO injected embryos are subsequently injected with ogt variant 4 mRNA, the fraction of wild type embryos increases from less than 10% to more than 50% (Fig. 3). This rescue rules out potential off-target effects of the MOs.
###end p 23
###begin p 24
###xml 50 54 50 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 0 63 0 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Tissues from all three germ layers are reduced in <italic>ogt </italic>morphants</bold>
###xml 79 83 79 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 419 421 419 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B86">86</xref>
###xml 610 615 610 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink">emx1 </italic>
###xml 675 679 675 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flh </italic>
###xml 739 746 739 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink">krox20 </italic>
###xml 774 778 774 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 831 843 827 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tropomyosin </italic>
###xml 874 878 870 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 991 997 987 993 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sox17 </italic>
###xml 1079 1083 1075 1079 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
Tissues from all three germ layers are reduced in ogt morphants. Comparison of ogt morphants and hOga expressing embryos with controls at 24 hpf (A-R) or 8 hpf (S-U). (B) Embryos injected with 7.5 ng MO1 (B), MO2 (C) or hOga (D) were smaller than controls (A), and had curved tails, small brains, reduced or absent eyes and shortened body axes. Necrotic tissue in the head from the MO injection is indicated (C, arrow)[86]. An Ogt-gfp fusion protein is translated in the presence of control MOs (E), but not in the presence of MO1 (F). In embryos injected with MO1 (H, K, arrowhead) or hOga (I, L, arrowhead), emx1 expression is slightly reduced compared to controls (G) and flh expression in the epiphysis is normal or slightly expanded. krox20 is expression is reduced in ogt morphants (N) and hOga expressing embryos (O). alpha-tropomyosin is reduced and disorganized in ogt morphants (Q) and hOga overexpressing embryos (R), reflecting the disorganization of the entire body axis. Fewer sox17 expressing endodermal precursor cells and dorsal forerunner cells are apparent in ogt morphants (T, arrowhead) and hOga overexpressing embryos (U, arrowhead). (V) Extracts from embryos injected with control MO (lane 1), MO1 (lane 2) or MO2 (lane 3) were probed with the RL2 monoclonal antibody (upper) or anti-tubulin antibody (lower). (W) Embryos injected with the control MO have 35% more O-GlcNAc modified protein than embryos injected with MO1 and 20% more than embryos injected with MO2. Anterior is to the left in A-R, dorsal views in S-U. e = eyes. Representative embryos are shown.
###end p 24
###begin p 25
###xml 10 14 10 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 40 54 40 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">variant 4 ogt </italic>
###xml 0 58 0 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Rescue of <italic>ogt </italic>morphants by injection of <italic>variant 4 ogt </italic>mRNA</bold>
###xml 82 86 82 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 120 134 117 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">galactosidase </italic>
###xml 152 167 149 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogta variant 4 </italic>
###xml 307 311 304 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 346 360 340 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">galactosidase </italic>
###xml 381 396 375 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogta variant 4 </italic>
###xml 420 434 414 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">variant 4 ogt </italic>
###xml 462 477 456 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogta variant 4 </italic>
Rescue of ogt morphants by injection of variant 4 ogt mRNA. Lateral views of live ogt morphant injected with 50 pg beta-galactosidase mRNA (A) or 50 pg ogta variant 4 mRNA (B). The image in A depicts the mild range of defects observed in morphants. (C) Graph depicting the frequency of wild type embryos in ogt morphants injected with 50 pg beta-galactosidase mRNA (lane 1), 10 pg ogta variant 4 mRNA (lane 2), or 50 pg variant 4 ogt mRNA (lane 3). Injection of ogta variant 4 mRNA significantly increases the frequency of normal embryos.
###end p 25
###begin p 26
###xml 147 155 147 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt-gfp </italic>
###xml 310 312 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2E</xref>
###xml 444 446 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2F</xref>
###xml 517 521 517 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 747 749 747 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2V</xref>
###xml 1023 1025 1023 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2V</xref>
###xml 1217 1222 1217 1222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2V, W</xref>
To confirm that the MOs reduce Ogt levels, we asked if they could efficiently prevent translation of an Ogt-gfp fusion protein. Embryos expressing ogt-gfp mRNA produce high levels of the fusion protein, as indicated by GFP fluorescence. Control MOs have no effect on fluorescence levels in these embryos (Fig. 2E; N = 30). In the presence of MO1, however, fluorescence levels decreased below the level of background yolk autofluorescence (Fig. 2F; N = 30). This suggests that the MO efficiently blocks translation of ogt transcripts and reduces the level of endogenous Ogt protein. To determine if the MOs reduced global O-GlcNAc levels, we performed Western blots on protein extracts from 18 hpf embryos using an O-GlcNAc specific antibody (Fig. 2V). For this analysis, we made protein extracts from embryos injected with MO1 or MO2 that displayed aberrant morphology and from embryos injected with a control MO that had normal morphology. We used the RL2 monoclonal antibody to recognize O-GlcNAc modified proteins (Fig. 2V). Quantification of all the bands revealed that total O-GlcNAc levels are reduced by 35% in embryos injected with MO1 as compared with controls, and by 20% in embryos injected with MO2 (Fig. 2V, W). This is consistent with a reduction in endogenous Ogt protein levels in MO injected embryos.
###end p 26
###begin p 27
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 145 149 145 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">oga </italic>
###xml 302 304 302 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D</xref>
###xml 348 352 348 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 125 130 <span type="species:ncbi:9606">human</span>
To determine if the defects in ogt morphants are due to reductions in O-GlcNAc levels, we expressed 250 pg mRNA encoding the human orthologue of oga (hOga; gi: 10835355). We found that hOga expressing embryos have a shortened body axis, reduced heads, small or absent eyes and twisted notochords (Fig. 2D). These defects strongly resemble those in ogt morphants, confirming that reducing O-GlcNAc levels has severe consequences on embryonic development. We conclude that O-GlcNAc modifications control the activity of proteins involved in controlling embryonic development.
###end p 27
###begin title 28
###xml 62 65 62 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt</italic>
Derivatives of ectoderm, mesoderm and endoderm are reduced in ogt-depleted embryos
###end title 28
###begin p 29
###xml 130 134 130 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 147 155 147 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 258 259 258 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 365 370 365 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">emx1 </italic>
###xml 447 449 447 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2G</xref>
###xml 452 454 452 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 461 466 461 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">emx1 </italic>
###xml 539 541 539 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2H</xref>
###xml 667 681 667 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">floating head </italic>
###xml 682 685 682 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flh</italic>
###xml 714 716 714 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2J</xref>
###xml 730 732 730 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 781 785 781 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flh </italic>
###xml 828 832 828 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 873 875 873 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2K</xref>
###xml 943 948 943 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink">emx1 </italic>
###xml 952 956 952 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flh </italic>
###xml 1031 1035 1031 1035 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 1139 1146 1139 1146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">krox20 </italic>
###xml 1152 1154 1152 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2M</xref>
###xml 1157 1159 1157 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 1187 1194 1187 1194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">krox20 </italic>
###xml 1288 1290 1288 1290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2N</xref>
###xml 1361 1366 1361 1366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">emx1 </italic>
###xml 1414 1418 1414 1418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 1434 1436 1434 1436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2I</xref>
###xml 1448 1452 1448 1452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flh </italic>
###xml 1488 1490 1488 1490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2L</xref>
###xml 1511 1518 1511 1518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">krox20 </italic>
###xml 1612 1614 1612 1614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2O</xref>
To understand the processes controlled by O-GlcNAc modifications, we performed an extensive analysis of the cell types present in ogt morphants by in situ hybridization. A table of the probes used and the tissues they mark is presented in the Methods (Table 1). We first examined expression of genes that mark derivatives of the neurectoderm, mesoderm or endoderm. emx1 marks the dorsal telencephalon in embryos injected with the control MO (Fig. 2G) [53]. The emx1 expression domain is slightly reduced in embryos injected with MO1 (Fig. 2H; N = 20) or MO2 (data not shown; N = 25). Another structure in the dorsal telencephalon, called the epiphysis, expresses the floating head (flh) transcription factor (Fig. 2J, arrowhead) [54]. Even in cases of dramatically reduced brains, flh is expressed normally in the forebrains of ogt morphants, or is expanded slightly (Fig. 2K, N = 30; MO2 data not shown, N = 30). The consistent expression of emx1 and flh indicates that the dorsal telencephalon forms and is normally patterned in ogt morphants. In the segmented hindbrain, rhombomeres 3 and 5 express the zinc finger transcription factor krox20 (Fig. 2M) [55]. In Ogt-depleted embryos, krox20 is still expressed in two stripes, although expression in rhombomere 3 is often reduced (Fig. 2N, N = 30; MO2 data not shown, N = 27). In embryos overexpressing hOga, emx1 is expressed in the dorsal telencephalon, as in ogt morphants (Fig. 2I; 4/6), and flh is expressed in the epiphysis (Fig. 2L; 5/7). In addition, krox20 transcripts are detected in rhombomeres 3 and 5, although rhombomere 3 is often reduced (Fig. 2O; 7/10). Thus, the anterior-posterior patterning of the brain is normal when O-GlcNAc levels are decreased, but the amount of tissue is slightly reduced in the forebrain and hindbrain.
###end p 29
###begin p 30
###xml 75 79 75 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 205 217 201 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tropomyosin </italic>
###xml 223 225 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2P</xref>
###xml 228 230 224 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 257 269 249 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tropomyosin </italic>
###xml 380 382 372 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2Q</xref>
###xml 485 491 477 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sox17 </italic>
###xml 545 547 537 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2S</xref>
###xml 550 552 542 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 568 574 560 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sox17 </italic>
###xml 637 639 629 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2S</xref>
###xml 689 691 681 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 719 725 711 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sox17 </italic>
###xml 880 882 872 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2S</xref>
###xml 887 889 879 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2T</xref>
###xml 952 954 944 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2T</xref>
###xml 1057 1059 1049 1051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2R</xref>
###xml 1155 1157 1147 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2U</xref>
###xml 1214 1216 1206 1208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2U</xref>
###xml 1296 1300 1288 1292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
Derivatives of the mesoderm and endoderm are reduced and disorganized when ogt function is reduced. Within the mesoderm, slow muscle forms in the somites on either side of the midline, and expresses alpha-tropomyosin (Fig. 2P) [56]. In the morphants, alpha-tropomyosin expression reveals the presence of slow muscle tissue in a reduced number of highly disorganized somites (Fig. 2Q, 12/19; MO2 data not shown 9/15). Endoderm precursors are apparent during gastrulation, as individual sox17 expressing cells migrate toward the animal pole (Fig. 2S) [57]. In addition, sox17 is expressed in a small group of dorsal forerunner cells (Fig. 2S, arrowhead), which are not of endodermal origin [58]. Endodermal expression of sox17 is significantly reduced in the morphants, indicating that the embryos have fewer endoderm precursors than embryos injected with control MOs (compare Fig. 2S and 2T). The morphants also have fewer dorsal forerunner cells (Fig. 2T). Embryos expressing hOga strongly resemble the morphants, and have fewer somites than controls (Fig. 2R; 5/7). In addition, hOga expressing embryos have significantly fewer endoderm precursors (Fig. 2U; 17/25) and dorsal forerunner cells than controls (Fig. 2U, arrowhead). The reduction of ectodermal, mesodermal and endodermal tissues in ogt morphants and hOga expressing embryos suggests that O-GlcNAc modifications regulate cell proliferation, survival, or cell fate determination.
###end p 30
###begin title 31
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
Induction of mesoderm and endoderm are normal in ogt morphants
###end title 31
###begin p 32
###xml 268 272 268 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 330 340 330 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">brachyury </italic>
###xml 350 358 350 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">no-tail </italic>
###xml 359 362 359 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ntl</italic>
###xml 488 490 488 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 493 495 493 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 555 557 555 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 620 624 620 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flh </italic>
###xml 673 683 673 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink">goosecoid </italic>
###xml 726 728 726 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 731 733 731 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 734 736 734 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 744 748 744 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flh </italic>
###xml 769 773 769 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsc </italic>
###xml 840 846 840 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mezzo </italic>
###xml 968 970 968 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4G</xref>
###xml 973 975 973 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 978 984 978 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mezzo </italic>
###xml 998 1002 998 1002 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 1018 1020 1018 1020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4F</xref>
###xml 1094 1096 1094 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4E</xref>
###xml 1214 1218 1214 1218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 1433 1437 1433 1437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
The dramatic reduction in endoderm and the more subtle reduction in mesoderm and ectodermal derivatives could be explained by a failure to properly specify the germ layers before gastrulation. Therefore we examined expression of early mesoderm and endoderm markers in ogt morphants during the pregastrula stages. In controls, the brachyury homologue no-tail (ntl) is expressed in a marginal ring that includes all mesoderm and endoderm precursors at 5 hpf, as in wild type (N = 15) (Fig. 4A) [59]. This expression is not altered by injection of MO1 (Fig. 4B, N = 25) or MO2 (data not shown). Within the dorsal mesoderm, flh is expressed in the presumptive notochord, while goosecoid is expressed in the prechordal plate (Fig. 4C) [59,60]. Both flh (data not shown) and gsc (4D, N = 25) are expressed normally in the morphants. Finally, the mezzo transcription factor acts downstream of Nodal signals to specify endoderm, and is expressed in a ring at the margin (Fig. 4G) [61]. Mezzo expression in ogt morphants (Fig. 4F, N = 30) is indistinguishable from those injected with control MOs (Fig. 4E). Thus, the expression of early markers for mesoderm and endoderm appears normal when O-GlcNAc levels are reduced in ogt morphants. Therefore, we could find no evidence that O-GlcNAc modifications control the initial specification of the germ layers or establishment of the body axes. Instead, we conclude that morphological defects in ogt morphants observed at later stages are caused by the failure of precursor cells to survive or proliferate, or by aberrant morphogenesis.
###end p 32
###begin p 33
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 0 62 0 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Induction of mesoderm and endoderm are normal in <italic>ogt </italic>morphants</bold>
###xml 153 157 153 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ntl </italic>
###xml 283 287 283 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsc </italic>
###xml 335 339 335 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 375 381 375 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mezzo </italic>
###xml 472 478 472 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mezzo </italic>
Induction of mesoderm and endoderm are normal in ogt morphants. Animal pole views of 5 hpf embryos (A, B, E, F) or dorsal views of 6 hpf embryos (C, D). ntl is expressed in the ring mesoderm and endodermal precursors around the margin in control MO (A) and MO1 (B) injected embryos. gsc (C, D) is expressed in dorsal marginal cells in ogt morphants (O) and controls (C). The mezzo transcription factor is expressed in a ring of endoderm precursors in control embryos (E). mezzo expression in the morphants is indistinguishable from controls (F).
###end p 33
###begin title 34
###xml 49 58 49 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 62 69 62 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Variant 2 and Variant 4 Ogta isoforms are active in vitro and in vivo
###end title 34
###begin p 35
###xml 234 243 234 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 333 334 333 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 395 404 395 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 432 434 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 554 556 554 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 633 635 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 852 854 852 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 901 905 901 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vivo</italic>
###xml 1313 1318 1310 1315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5H, I</xref>
###xml 1376 1385 1373 1382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1389 1396 1386 1393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 677 686 <span type="species:ncbi:7955">zebrafish</span>
###xml 724 729 <span type="species:ncbi:9606">human</span>
Since tissues are reduced when Ogt is depleted, we asked if they are expanded when Ogt levels are increased. First, we asked if the variant 2 and variant 4 proteins encoded by our constructs displayed O-GlcNAc transferase activity in in vitro assays. We measured the ability of the bacterially expressed Ogt proteins to incorporate [3H]GlcNAc onto a synthetic CKII peptide, the best established in vitro acceptor substrate for Ogt [34]. A western blot of the bacterial lysates reveals that equivalent amounts of enzymes were added to the reactions (Fig. 5A). Both the variant 2 and variant 4 isoforms were active in this assay (Fig. 5A), although the specific activity of both zebrafish proteins is significantly lower than human Ogt in the same assay (data not shown). These results contrast to previous results indicating that variant 2 is inactive [46]. To test whether the isoforms were active in vivo, we injected embryos with 500 pg of mRNA encoding either beta-galactosidase, variant 2 or variant 4 Ogta protein. We performed a Western blot on extracts from these embryos using the RL2 antibody, which is specific to the O-GlcNAc modification (see methods). In two separate experiments, O-GlcNAc levels were 30-50% higher in embryos overexpressing either variant 4 or variant 2 Ogta than in controls (Fig. 5H, I). We conclude that Ogta variants 2 and 4 are active both in vitro and in vivo.
###end p 35
###begin p 36
###xml 49 58 49 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 62 69 62 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 0 69 0 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Variant 2 and variant 4 Ogta proteins are active <italic>in vitro </italic>and <italic>in vivo</italic></bold>
###xml 75 84 75 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 540 554 537 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink">galactosidase </italic>
###xml 567 582 564 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink">variant 4 ogta </italic>
###xml 598 612 595 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">variant 2 ogt </italic>
###xml 647 661 641 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">galactosidase </italic>
###xml 711 726 705 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink">variant 4 ogta </italic>
###xml 1084 1099 1078 1093 <italic xmlns:xlink="http://www.w3.org/1999/xlink">variant 2 ogta </italic>
###xml 1284 1303 1278 1294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;-galactosidase </italic>
###xml 1313 1328 1304 1319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">variant 2 ogta </italic>
###xml 1338 1353 1329 1344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">variant 4 ogta </italic>
###xml 296 301 <span type="species:ncbi:9606">human</span>
Variant 2 and variant 4 Ogta proteins are active in vitro and in vivo. (A) in vitro Ogt activity assay of bacterially expressed, HIS-tagged variant 2 Ogta and variant 4 Ogta proteins. Both enzymes incorporate significant amounts of [3H]UDP-GlcNAc onto the synthetic CKII peptide identical to the human sequence, although variant 4 Ogta is more active than variant 2. A western blot of the bacterial lysates reveals that equivalent amounts of enzyme were added to the reactions. (B-G) Images of live 24 hpf embryos injected with 500 pg beta-galactosidase mRNA (B, C), variant 4 ogta mRNA (D, E), or variant 2 ogt (F, G). Embryos injected with beta-galactosidase mRNA developed normally (B, C). Overexpression of variant 4 ogta mRNA resulted in three phenotypic classes of embryos at this stage. Class I embryos had a visible, but shortened, body axis and reduced brain, including reduced or absent eyes (D). The body axis in Class II embryos was strongly reduced and in many cases, not discernable (E). Class III embryos are indistinguishable from wild type (not shown). Expression of variant 2 ogta mRNA produced the same range of phenotypes, including Class I (F) and Class II (G) embryos. (H, I) Western blot of protein extracts of 18 hpf embryos injected with 500 pg mRNA encoding beta-galactosidase (lane 1), variant 2 ogta (lane 2), variant 4 ogta (lane 3). The blot was probed with the RL2 antibody, which recognizes the O-GlcNAc modification. This experiment was performed in biological duplicate (I) Quantification of the blot shown in (H, set 1) and a technical duplicate (set 2). B and C are duplicate images of the same control embryo.
###end p 36
###begin p 37
###xml 100 105 100 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogta </italic>
###xml 128 133 128 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogta </italic>
###xml 310 311 310 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 393 407 390 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">galactosidase </italic>
###xml 458 463 455 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B, C</xref>
###xml 659 663 656 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 681 683 678 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5D</xref>
###xml 711 716 708 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B, C</xref>
###xml 848 850 845 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5E</xref>
###xml 951 965 945 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink">galactosidase </italic>
###xml 1254 1259 1248 1253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5F, G</xref>
To test the effect of increasing O-GlcNAc levels on embryonic development, we injected embryos with ogta mRNA. 100 pg or 250 pg ogta mRNA did not affect embryonic development (data not shown). By contrast, 500 pg mRNA encoding either variant 4 or variant 2 Ogta caused severe developmental abnormalities (Fig. 5). These defects are specific, since control embryos injected with 500 pg of beta-galactosidase mRNA were indistinguishable from wild type (Figure 5B, C). Overexpression of variant 4 Ogta generated three classes of embryos at 24 hpf. Class I embryos had mildly reduced heads, eyes, notochords, and a shortened body axis similar to that observed in ogt morphants (Figure 5D, 23/129; compare with Fig. 2B, C). Class II embryos had more severe defects, including greatly reduced heads, missing eyes and no distinguishable body axis (Figure 5E; 20/129). Finally, class III embryos were indistinguishable from control embryos injected with beta-galactosidase mRNA (data not shown; 35/129). The remaining embryos, comprising the largest group, died soon after gastrulation and therefore are not counted in the phenotypic classes at 24 hpf (51/129; see below). Overexpression of variant 2 Ogta produced similar defects at similar frequencies (Figure 5F, G). These results demonstrate that elevated O-GlcNAc levels disrupt embryonic development.
###end p 37
###begin title 38
Ogt overexpression disrupts the ectoderm, mesoderm and endoderm
###end title 38
###begin p 39
###xml 333 338 333 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">emx1 </italic>
###xml 414 416 414 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6H</xref>
###xml 453 455 453 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6O</xref>
###xml 498 526 495 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">galactosidase galactosidase </italic>
###xml 554 556 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 559 563 556 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flh </italic>
###xml 618 620 615 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6I</xref>
###xml 652 654 649 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 738 740 735 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6P</xref>
###xml 877 884 874 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pax2.1 </italic>
###xml 937 939 934 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6C</xref>
###xml 1002 1004 999 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 1027 1034 1024 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pax2.1 </italic>
###xml 1088 1090 1085 1087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6J</xref>
###xml 1187 1191 1184 1188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flh </italic>
###xml 1250 1252 1247 1249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6Q</xref>
###xml 1290 1297 1287 1294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">krox20 </italic>
###xml 1363 1365 1360 1362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6K</xref>
###xml 1405 1407 1402 1404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6D</xref>
###xml 1513 1520 1510 1517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">krox20 </italic>
###xml 1537 1539 1534 1536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6R</xref>
###xml 1738 1750 1731 1743 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tropomyosin </italic>
###xml 1756 1758 1749 1751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6E</xref>
###xml 1842 1844 1835 1837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6L</xref>
###xml 1872 1874 1865 1867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6S</xref>
###xml 2003 2009 1996 2002 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sox17 </italic>
###xml 2034 2036 2027 2029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6F</xref>
###xml 2041 2043 2034 2036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6M</xref>
###xml 2078 2084 2071 2077 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sox17 </italic>
###xml 2120 2122 2113 2115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6T</xref>
###xml 2125 2131 2118 2124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sox17 </italic>
###xml 2231 2236 2224 2229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6M, T</xref>
###xml 2328 2333 2321 2326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hgg1 </italic>
###xml 2339 2341 2332 2334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6G</xref>
###xml 2344 2346 2337 2339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 2349 2354 2342 2347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hgg1 </italic>
###xml 2393 2395 2386 2388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6N</xref>
###xml 2423 2425 2416 2418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6U</xref>
To determine which tissues are affected by increasing O-GlcNAc levels, we performed marker gene analysis on Ogt overexpressing embryos. In the experiments described below, we obtained similar effects for both Ogta variants. Unless otherwise indicated, we describe only those from embryos overexpressing Ogta variant 4. Expression of emx1 indicates that the dorsal telencephalon is present in Class I embryos (Fig. 6H, N = 20) and Class II embryos (Fig. 6O), and is roughly the same size as in beta-galactosidase galactosidase mRNA injected embryos (Fig. 6A). flh is expressed in the epiphysis in Class I embryos (Fig. 6I; N = 20), as in controls (Fig. 6B, arrowhead). The epiphysis is greatly reduced or missing in Class II embryos (Fig. 6P, arrowhead), indicating that the size of the epiphysis varies widely in Ogta expressing embryos. In the brain, the transcription factor pax2.1 is expressed at the mid-brain/hind-brain (MHB) (Fig. 6C, arrowhead) boundary and in the more posterior otic vesicles [62]. In class I embryos, pax2.1 expression in the MHB boundary is not perturbed (Fig. 6J, arrowhead; 10/20), but the otic vesicles are often abnormally positioned. In class II embryos, flh expression at the MHB boundary is severely disrupted (Fig. 6Q, arrowhead; 5/20). In the hindbrain, krox20 stripes are normal, or slightly narrower in class I embryos (Fig. 6K; N = 25) as compared to controls (Fig. 6D). In class II embryos, the hindbrains are highly disorganized, and often display only a single stripe of krox20 expression (Fig. 6R). Thus tissues in the forebrain, mid-brain, and hindbrain are present, but are reduced and disorganized to varying extents in Ogt overexpressing embryos. Expression of the slow muscle marker, alpha-tropomyosin (Fig. 6E), is expressed in a reduced number of highly disorganized somites in Class I (Fig. 6L; 14/20) and Class II (Fig. 6S) embryos. In addition, both classes of embryos have fewer endoderm precursors at mid-gastrulation than controls, as revealed by sox17 expression (compare Fig. 6F and 6M). In class II embryos, only a few sox17 expressing cells are detected (Fig. 6T). sox17 expression in the dorsal forerunner cells is reduced or absent in both class I and II embryos (Fig. 6M, T, arrowheads). The hatching gland, a derivative of the prechordal plate, expresses the gene hgg1 (Fig. 6G) [63]. hgg1 expression is reduced in class I (Fig. 6N; 12/20) and class II (Fig. 6U) embryos. The reduced and disorganized endodermal, ectodermal and mesodermal tissue in Ogt overexpressing embryos strongly resembles the defects in embryos with reduced O-GlcNAc levels. Thus, increasing or decreasing O-GlcNAc levels results in similar defects. This indicates that O-GlcNAc levels must be tightly regulated within a narrow range for normal development to occur.
###end p 39
###begin p 40
###xml 0 76 0 76 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Tissues from all three germ layers are reduced in Ogt overexpressing embryos</bold>
###xml 273 278 273 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">emx1 </italic>
###xml 369 373 369 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flh </italic>
###xml 499 506 499 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pax2.1 </italic>
###xml 626 633 626 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pax2.1 </italic>
###xml 732 739 732 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">krox20 </italic>
###xml 908 920 904 916 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tropomyosin </italic>
###xml 1050 1056 1046 1052 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sox17 </italic>
###xml 1249 1254 1245 1250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hgg1 </italic>
Tissues from all three germ layers are reduced in Ogt overexpressing embryos. Analysis of defects in Class I (H-N) and Class II (O-U) Ogt overexpressing embryos, compared to controls (A-G). Embryos at 24 hpf (A-E, H-L, O-S), 8 hpf (F, M, T) and 14 hpf (G, N, U) are shown. emx1 expression in class I (H) and class II (O) embryos is indistinguishable from controls (A). flh expression is slightly expanded in class I (I, arrowhead) and reduced in class II (P, arrowhead) embryos. In class I embryos, pax2.1 expression is normal in the MHB (J, arrowhead), whereas the otic vesicles are often disrupted (J). In class II embryos, pax2.1 expression is disrupted in the MHB (Q, arrowhead) and the otic vesicles are reduced or absent (Q). krox20 expression in rhombomeres 3 and 5 is indistinguishable in class I embryos (K) and controls (D). The rhombomeres are reduced and disrupted in class II embryos (R). alpha-tropomyosin expression is reduced and disorganized in class I embryos (L) and more severely reduced and disorganized in class II embryos (S). sox17 expression in endodermal precursors and dorsal forerunner cells is reduced in class I embryos (M) and severely reduced or absent in class II embryos (T) (arrowheads mark the forerunner cells). hgg1 is reduced in class I (N) and class II (U) embryos. Anterior to the left in A-E, H-L, O-S, dorsal views in F, M, T, and anterior views in G, N, U. e = eyes.
###end p 40
###begin title 41
Altering O-GlcNAc levels increases rates of cell death
###end title 41
###begin p 42
###xml 215 219 215 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A&#8211;D</xref>
###xml 276 290 273 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">galactosidase </italic>
###xml 327 342 324 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogta variant 4 </italic>
###xml 811 813 807 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7D</xref>
We next asked if the smaller size of Ogta expressing embryos could be explained by a reduction in cell number. To test this, we used flow cytometry to count cells in embryos overexpressing Ogt and in controls (Fig. 7A-D). We injected embryos with a combination of either beta-galactosidase mRNA and FITC-conjugated dextran, or ogta variant 4 mRNA and AlexaFluor-647-conjugated dextran. We mixed equal numbers of embryos from both groups at 18 hpf, when morphological differences between Ogt overexpressing embryos and the controls are apparent, and the embryos were homogenized to disperse the cells. In our analysis, we counted only cells in the 5-10 mum diameter range. In one experiment, we counted 67,711 cells in 20 control embryos and only 43,213 cells of the same size in 20 Ogt expressing embryos (Fig. 7D). Thus, control embryos contained 23% more cells than Ogt expressing embryos. Similar results were obtained in an independent experiment with fewer embryos (data not shown). This demonstrates that decreased cell number accounts for the reduced body size of Ogt overexpressing embryos.
###end p 42
###begin p 43
###xml 0 52 0 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Altering O-GlcNAc levels causes increased cell death</bold>
###xml 277 291 274 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">galactosidase </italic>
###xml 431 446 427 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">variant 4 ogta </italic>
###xml 584 598 576 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">galactosidase </italic>
###xml 620 635 612 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">variant 4 ogta </italic>
###xml 1200 1204 1191 1195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
Altering O-GlcNAc levels causes increased cell death. Flow cytometry of dissociated cells from 18 hpf embryos. (A) Distribution of cells from uninjected embryos showing the position of non-fluorescent cells and debris. (B) Distribution of cells from embryos injected with beta-galactosidase mRNA/FITC-dextran. The box indicates FITC positive cells between 5-10 mum in diameter. (C) Distribution of cells from embryos injected with variant 4 ogta mRNA/AlexaFluor-647-dextran. The box indicates AlexaFluor-647 positive cells between 5-10 mum in diameter. (D) Embryos injected with beta-galactosidase mRNA/FITC-dextran and variant 4 ogta mRNA/AlexaFluor-647-dextran were mixed, dissociated, and fluorescent cells between 5-10 mum diameter were counted. In this experiment, we counted 67,711 FITC positive cells and 43,213 AlexaFluor-647 positive cells. (E-H) Images of live 10 hpf embryos stained with acridine orange, which labels dying cells. All embryos are oriented with the tailbud at the bottom of the panel. (E) In controls, only a few acridine orange positive cells are detected, indicating a low rate of cell death. By contrast, a large number of acridine orange positive cells are observed in ogt morphants (F), Ogt overexpressing embryos (G) and hOga overexpressing embryos (H), indicating a high rate of cell death.
###end p 43
###begin p 44
###xml 255 257 255 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7E</xref>
###xml 286 301 286 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">variant 4 ogta </italic>
###xml 419 421 419 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7G</xref>
###xml 661 665 661 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 795 800 795 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7F, H</xref>
###xml 959 963 959 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
The reduced cell number in Ogt overexpressing embryos could be explained by either an increase in apoptosis or a decrease in cell division. At 8 hpf, control embryos have only a few dying cells, as assessed by the extent of acridine orange staining (Fig. 7E). By contrast, injection of variant 4 ogta mRNA dramatically increases the number of dying cells, as shown by the increase in acridine orange fluorescence (Fig. 7G). Ogt overexpressing embryos have more dying cells than controls at every time point examined between 8 hpf and 24 hpf (data not shown). Thus, increased cell death could account for the decreased cell number in Ogt overexpressing embryos. ogt morphants and hOga expressing embryos display a similarly dramatic increase in the number of acridine orange staining cells (Fig. 7F, H). Thus, embryos with reduced levels of O-GlcNAc display elevated rates of cell death. The resulting decrease in cell number could explain the smaller size of ogt morphants and hOga expressing embryos. These results also confirm our earlier conclusion that the defects resulting from decreased levels of O-GlcNAc are similar to those observed in Ogt overexpressing embryos.
###end p 44
###begin title 45
OGT overexpression causes defective morphogenesis
###end title 45
###begin p 46
###xml 395 399 395 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ntl </italic>
###xml 434 436 434 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8A</xref>
###xml 479 483 479 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ntl </italic>
###xml 567 569 567 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8B</xref>
###xml 593 597 593 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ntl </italic>
###xml 653 655 653 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8C</xref>
###xml 658 663 658 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MyoD </italic>
###xml 745 747 745 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8D</xref>
###xml 864 866 864 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8E</xref>
###xml 869 871 869 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
###xml 963 965 963 965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8E</xref>
###xml 1058 1060 1058 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8F</xref>
Although the increase in cell death could explain the reduced size of Ogt overexpressing embryos, it does not explain their aberrant morphology. To better understand when the embryos become disorganized, we examined markers of axial and paraxial mesoderm just after gastrulation, and during the segmentation stages. In control embryos after gastrulation, the cells of the axial mesoderm express ntl and extend along the midline (Fig. 8A). In Ogt expressing embryos, by contrast, ntl expression is truncated along the midline, resulting in a shortened body axis (Fig. 8B). In class II embryos, ntl expression is completely restricted to the margin (Fig. 8C). MyoD is expressed early in the segmented mesoderm that gives rise to the somites (Fig. 8D). Ogt expressing embryos have fewer somites than controls, with somites often forming in only half the embryo (Fig. 8E) [64]. In addition, the somites in class I embryos are often wider than those in controls (Fig. 8E). In class II embryos, the somites are extremely broad and nearly encircle the embryo (Fig. 8F). The aberrant morphology of the axial and paraxial mesoderm suggests that Ogt expression disrupts the morphogenetic movements associated with gastrulation.
###end p 46
###begin p 47
###xml 0 65 0 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Mesodermal derivatives are disorganized in Ogt expressing embryos</bold>
###xml 105 113 105 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 151 155 151 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ntl </italic>
###xml 207 211 207 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ntl </italic>
###xml 263 267 263 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ntl </italic>
###xml 368 373 368 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MyoD </italic>
Mesodermal derivatives are disorganized in Ogt expressing embryos. Images of fixed embryos processed for in situ hybridization to reveal expression of ntl at 10 hpf (A-C) or MyoD at 14 hpf (D-F). At 10 hpf, ntl is expressed in the axial mesoderm in controls (A). ntl expression is truncated (B) in class I embryos, and more severely truncated in class II embryos (C). MyoD marks trunk somites on either side of the midline at 14 hpf (D). Some somites are missing in class I embryos, but many of the remaining somites are abnormally wide (E). In class II embryos, somites extend around the circumference of the embryos (F).
###end p 47
###begin title 48
OGT overexpression causes delays in epiboly
###end title 48
###begin p 49
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
###xml 194 195 194 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 353 354 353 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
###xml 635 640 635 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9A, E</xref>
###xml 759 764 759 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9B, F</xref>
###xml 949 951 949 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9F</xref>
###xml 1049 1051 1049 1051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9C</xref>
###xml 1175 1177 1175 1177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9G</xref>
###xml 1420 1434 1417 1431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">galactosidase </italic>
###xml 1485 1487 1482 1484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9D</xref>
###xml 1554 1556 1551 1553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9H</xref>
###xml 1648 1662 1645 1659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">variant 2 ogt </italic>
###xml 40 49 <span type="species:ncbi:7955">zebrafish</span>
The first morphogenetic movement in the zebrafish embryo, called epiboly, begins before gastrulation when the blastoderm thins and spreads over the entire yolk [65]. As reported above (see Fig. 5), a large fraction of Ogt overexpressing cells die before 24 hpf, and many embryos examined before this stage had signs of defective morphogenesis (see Fig. 8). To determine if epiboly is disrupted by Ogt overexpression, we monitored the development of live embryos during a time course from 3-12 hpf. Ogt overexpressing embryos develop at the same rate as controls during the cleavage stages, and reach the 1000-cell stage at 3 hpf (Fig. 9A, E). Epiboly begins at 4.3 hpf in Ogt overexpressing embryos, as in wild type, and they reach 40% epiboly at 5 hpf (Fig. 9B, F). Occasional blastomeres separate from the blastoderms of Ogt overexpressing embryos during this period, and the remaining blastomeres are unevenly distributed around the margin (Fig. 9F). Gastrulation begins at 6 hpf, and control embryos reach mid-gastrulation two hours later (Fig. 9C). During the same time, epiboly does not progress in Ogt overexpressing embryos, which appear stalled at 40% epiboly (Fig. 9G). Less severely affected embryos progress through epiboly at a slower rate (data not shown). Thus, increased Ogt activity delays the late phase of epiboly, but does not affect the onset or initial progression of epiboly. At 12 hpf, when beta-galactosidase expressing embryos are at the 3-somite stage (Fig. 9D), a large fraction of Ogt overexpressing embryos degenerate (Fig. 9H; 52/129). We observed similar defects along the same time course in embryos overexpressing variant 2 ogt mRNA and hOga (data not shown). We conclude that O-GlcNAc modifications control the activity of one or more proteins involved in the progression through epiboly.
###end p 49
###begin p 50
###xml 0 44 0 44 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Epiboly is delayed in Ogt expressing embryos</bold>
###xml 114 133 114 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;-galactosidase </italic>
###xml 180 194 177 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">variant 4 ogt </italic>
###xml 311 315 308 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
Epiboly is delayed in Ogt expressing embryos. A live time-course embryonic development of an embryo injected with beta-galactosidase mRNA (A-D) or a sibling injected with encoding variant 4 ogt mRNA (E-H) at 3 hpf (A, E), 5 hpf (B, F), 8 hpf (C, G) and 12 hpf (D, H). Progression through the cleavage stages in ogt overexpressing embryos (E) is indistinguishable from controls (E). Epiboly initiates normally when Ogt is overexpressed, and these embryos reach 40% epiboly at 5 hpf (B), the same as controls (F). Ogt overexpressing embryos are stalled at 40% epiboly at 8 hpf (G), when controls are at 75% epiboly (G). Control embryos complete epiboly at 10 hpf and reach the 3 somite stage at 12 hpf (D). The most severely affected Ogt overexpressing embryos never complete epiboly and begin to degenerate at 12 hpf (H).
###end p 50
###begin title 51
Ogt and hOga overexpression disrupts yolk microtubules and actin filaments
###end title 51
###begin p 52
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
###xml 361 363 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
###xml 593 599 589 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10A, D</xref>
###xml 627 629 623 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 735 741 731 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10B, E</xref>
###xml 807 812 803 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8D, E</xref>
###xml 1038 1044 1034 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10C, F</xref>
Disruption of the microtubule (MT) or actin-based cytoskeletal network in the yolk disrupts epiboly in a similar manner to that observed in Ogt and hOga overexpressing embryos [66-68]. Therefore we asked if the yolk cytoskeleton is disrupted when the enzymes are overexpressed. To examine the MT network, we utilized the antibody against alpha-tubulin (12G10) [69]. In 4 hpf controls, Z-projections of confocal images reveal a short latticework of MTs connecting the nuclei within the YSL and a network of longer MTs extending through the cortical yolk cytoplasm toward the vegetal pole (Fig. 10A, D), as previously described [67]. When Ogt activity is elevated, the MTs are shortened and they do not interconnect within the YSL (Fig. 10B, E). In addition, the MT filaments appear thicker than normal (Fig. 8D, E arrowheads). These results demonstrate that elevated Ogt activity disrupts the MT arrays in the yolk, either directly or indirectly. Similarly, the MT filaments appear shorter and thicker in embryos overexpressing hOga (Fig. 10C, F, arrowhead). This indicates that increasing or decreasing O-GlcNAc levels disrupts that yolk MT network.
###end p 52
###begin p 53
###xml 0 64 0 64 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Ogt overexpressing embryos have defects in the yolk cytoskeleton</bold>
###xml 142 156 139 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">galactosidase </italic>
###xml 175 189 172 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">variant 4 ogt </italic>
###xml 211 216 208 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hOga </italic>
Ogt overexpressing embryos have defects in the yolk cytoskeleton. Confocal z-stacks of immunofluorescent images of embryos injected with beta-galactosidase mRNA (A, D, G, J), variant 4 ogt mRNA (B, E, H, K) and hOga mRNA (C, F, I, L). Embryos at 4 hpf were incubated with the 12G10 1degrees antibody to reveal microtubule filaments (A-F) and 8 hpf embryos were incubated with rhodamine phalloidin (G-L). 12G10 reactivity reveals mitotic spindles in the blastomeres of controls embryos (A) Ogt expressing embryos (B) and hOga embryos (C). Within the yolk, long MT arrays extend around through the cortical cytoplasm toward the vegetal pole (A, D, arrowhead). In Ogt expressing embryos, many MTs appear thicker than normal and the arrays do not extend far towards the vegetal pole (B, E, arrowhead). Similarly, the MTs in the yolk are thicker than normal in hOga expressing embryos (F, arrowhead). Staining with rhodamine-phalloidin reveals actin filaments associated with the plasma membranes of EVL cells and the contractile actin ring in the yolk syncytial layer (YSL) (G-L). The contractile actin ring is apparent within the YSL of controls (G, J arrow), but not in OGT overexpressing embryos (H, K, arrow) or hOga expressing embryos (I, L, arrow). The EVL cells are highly irregular in size and shape in Ogt overexpressing embryos (H, K) and hOga expressing embryos (I, L). Red lines indicate the position of the YSL (A-C). Animal pole is to the top. Bars = 100 mum.
###end p 53
###begin p 54
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B70">70</xref>
###xml 256 262 256 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10G, J</xref>
###xml 363 369 363 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10H, K</xref>
###xml 388 394 388 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10I, L</xref>
###xml 496 502 496 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10G, J</xref>
###xml 511 513 511 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
###xml 597 599 597 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
###xml 700 706 700 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10H, K</xref>
###xml 809 815 809 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10I, L</xref>
In embryonic cells, F-actin associates with the cytoplasmic domain of E-cadherin in the cortical cytoplasm and decorates the cell membranes as visualized by rhodamine-phalloidin [70]. In control embryos, EVL cells are of roughly equal size and shape (Fig. 10G, J). By contrast, the shape and size of EVL cells are greatly disrupted by overexpression of Ogt (Fig. 10H, K) and of Oga (Fig. 10I, L). In controls, a punctate band of F-actin is detected within the YSL, underneath the EVL cells (Fig. 10G, J arrows)[68]. This band contracts during gastrulation and provides some force driving epiboly [68]. The band of actin in the YSL was missing in class I and class II Ogt overexpressing embryos (Fig. 10H, K, arrows). Similarly, the contractile actin ring was not detected in hOga overexpressing embryos (Fig. 10I, L). Thus, overexpressing hOga or Ogt results in a severe disruption of the actin and MT yolk cytoskeleton networks that drive epiboly movements.
###end p 54
###begin title 55
###xml 13 18 <span type="species:ncbi:9606">human</span>
Ogt modifies human POU5F1 protein
###end title 55
###begin p 56
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B71">71</xref>
###xml 206 208 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B72">72</xref>
###xml 248 254 248 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MZspg </italic>
###xml 308 310 308 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B71">71</xref>
###xml 323 328 323 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MZspg</italic>
###xml 442 444 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8F</xref>
###xml 447 449 447 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B72">72</xref>
###xml 494 500 494 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MZspg </italic>
###xml 578 583 578 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2T, U</xref>
###xml 590 595 590 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6M, T</xref>
###xml 597 599 597 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B73">73</xref>
###xml 1041 1043 1041 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11</xref>
###xml 1232 1234 1232 1234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11</xref>
###xml 1462 1464 1462 1464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B74">74</xref>
###xml 1465 1467 1465 1467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B75">75</xref>
###xml 792 801 <span type="species:ncbi:7955">zebrafish</span>
###xml 826 831 <span type="species:ncbi:9606">human</span>
###xml 868 873 <span type="species:ncbi:9606">human</span>
###xml 1086 1091 <span type="species:ncbi:9606">human</span>
###xml 1359 1364 <span type="species:ncbi:9606">human</span>
###xml 1369 1378 <span type="species:ncbi:7955">zebrafish</span>
###xml 1414 1423 <span type="species:ncbi:7955">zebrafish</span>
Some defects caused by increased levels of Ogt resemble those described in embryos lacking the maternal and zygotic function of the pou class transcription factor Spiel Ohne Grenzen/Oct4/Pou5f1 (MZSpg) [71,72]. The late phase of epiboly is delayed MZspg embryos, and cells in the EVL are irregularly shaped [71]. Secondly, MZspg embryos can display fused somites and truncated notochords, similar to those in embryos overexpressing Ogt (Fig. 8F) [72]. Finally, endoderm is reduced or absent in MZspg embryos, just as in embryos with increased or decreased O-GlcNAc levels (Fig. 2T, U; Fig. 6M, T)[73]. This raises the possibility that O-GlcNAc modifies Spg/Pou5f1 protein and regulates its function. Therefore, we asked if this protein is modified by O-GlcNAc. Since there is no antibody for zebrafish Spg/Pou5f1, we asked if human Pou5f1 is modified with O-GlcNAc in human embryonic stem cells (hESCs). We found that the O-GlcNAc specific monoclonal antibody RL-2 recognizes a 43 KDa protein immunoprecipitated by the Pou5f1 antibody (Fig. 11, left lane). This size is consistent with human Pou5f1 protein. Consistent with this, the same band reacts with the Pou5f1 polyclonal antibody when the blot is stripped and reprobed (Fig. 11, right lane). This demonstrates that Pou5f1 is modified by O-GlcNAc in hESCs. Given the high degree of homology between the human and zebrafish orthologues, it is likely that the zebrafish protein is also modified by O-GlcNAc [74,75]. It remains to be determined whether this modification regulates Spg/Pou5f1 activity.
###end p 56
###begin p 57
###xml 0 60 0 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 is modified by O-GlcNAc in human embryonic stem cells</bold>
###xml 34 39 <span type="species:ncbi:9606">human</span>
###xml 261 266 <span type="species:ncbi:9606">human</span>
Pou5f1 is modified by O-GlcNAc in human embryonic stem cells. Western blot of protein immunoprecipitated by an anti-Pou5f1 antibody. The RL2 antibody recognizes a 43 KDa, O-GlcNAc modified protein that is immunoprecipitated from the nucleocytosolic fraction of human ES cells (line BG02) by an anti-Pou5f1 antibody. The immunoprecipitation was specific, since the nucleocytosolic fraction was precleared with a mixture of IgG and A/G PLUS agarose prior to incubation with the anti-Pou5f1 antibody. The anti-Pou5f1 antibody recognizes the same band when the blot is stripped and reprobed, confirming that Pou5f1 protein is modified by O-GlcNAc.
###end p 57
###begin title 58
Discussion
###end title 58
###begin p 59
###xml 458 467 458 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 728 732 728 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 233 242 <span type="species:ncbi:7955">zebrafish</span>
In this work we used gain and loss of function experiments for the first time to study the role of Ogt and Oga during vertebrate development. We demonstrated that O-GlcNAc modifications control cell survival and epiboly movements in zebrafish embryos, but could find no evidence that they control early cell fate decisions. Furthermore, we observed the same range of defects whether Ogt protein was overexpressed or depleted. Since our enzymes are active in in vitro assays, this indicates that embryonic cells are highly sensitive to increases and decreases in the level of O-GlcNAc modifications. Finally, we identified Spg/Pou5f1 as a target for Ogt activity. These findings significantly extend previous genetic analyses of ogt function in embryos, and demonstrate that O-GlcNAc modifications regulate the activity of proteins involved in controlling morphogenetic movements.
###end p 59
###begin title 60
###xml 19 23 19 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 0 9 <span type="species:ncbi:7955">Zebrafish</span>
Zebrafish have two ogt paralogues
###end title 60
###begin p 61
###xml 45 49 45 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 70 75 70 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogta </italic>
###xml 79 83 79 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogtb</italic>
###xml 136 141 136 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A, B</xref>
###xml 312 321 312 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 322 324 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 413 414 413 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 492 501 492 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 507 509 507 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 845 850 845 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5F, G</xref>
###xml 1007 1021 1004 1018 <italic xmlns:xlink="http://www.w3.org/1999/xlink">galactosidase </italic>
###xml 1032 1033 1029 1030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 26 35 <span type="species:ncbi:7955">zebrafish</span>
Unlike other vertebrates, zebrafish have two ogt genes, which we call ogta and ogtb, which arose during a recent gene duplication (Fig. 1A, B). Previous studies showed that transcripts from both loci encode O-GlcNAc transferase proteins, although one isoform (variant 2) failed to modify full-length p62 protein in vitro [46]. Two lines of evidence indicate variant 2 Ogta can modify proteins other than p62 (Fig 5). First, this protein catalyzes the addition of O-GlcNAc to the CKII peptide in vitro (Fig. 5A). This demonstrates that variant 2 Ogta is catalytically active, but does not provide any information about the endogenous substrates of this enzyme. Secondly, overexpression of variant 2 in embryos causes similar defects as overexpression of variant 4 Ogt, which would not be expected if the protein were catalytically inactive (Fig. 5F, G). In support of this conclusion, we found that variant 2 expressing embryos had increased O-GlcNAc levels as compared to control embryos injected with beta-galactosidase mRNA (Fig. 5). We conclude that variant 2 Ogta is catalytically active. The apparent discrepancy between our results and those of Sohn and Do (2005) could be explained if variant 2 Ogta is unable to recognize p62, but can still recognize other substrates.
###end p 61
###begin p 62
###xml 72 77 72 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogta </italic>
###xml 81 85 81 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogtb</italic>
###xml 156 160 156 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 181 185 181 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 295 300 295 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2E, F</xref>
###xml 311 315 311 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 390 395 390 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2V, W</xref>
###xml 417 422 417 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogta </italic>
###xml 426 431 426 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogtb </italic>
###xml 499 506 499 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 530 534 530 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 590 594 590 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 605 606 605 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 731 735 731 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 751 753 751 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D</xref>
###xml 990 994 990 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 1081 1085 1081 1085 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
To reduce O-GlcNAc levels, we designed translation-blocking MOs against ogta and ogtb. Several lines of evidence indicate that the MOs specifically reduced ogt function. First, the ogt MOs prevented translation of mRNA encoding an Ogt-gfp fusion protein, whereas control MOs had no effect (Fig. 2E, F). Second, ogt MOs reduced the total amount of O-GlcNAc modifications in the embryo (Fig. 2V, W). This confirms that ogta and ogtb encode proteins that are required for O-GlcNAc transferase activity in vivo. Third, the defects in ogt morphants were rescued by co injection of a low dose of ogt mRNA (Fig. 3). Finally, overexpression of hOga, which removes O-GlcNAc from target proteins, caused similar defects to those observed in ogt morphants (Fig. 2D). The fact that MOs did not completely eliminate O-GlcNAc modifications can be explained by the persistence of Ogt protein translated from maternal transcripts prior to MO injection. In addition, each MO was designed to target only one ogt gene. Thus, Ogt protein continues to be synthesized from the non-targeted paralogue in ogt morphants.
###end p 62
###begin title 63
###xml 17 21 17 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
Gain and loss of ogt function produce similar defects
###end title 63
###begin p 64
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 94 99 94 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B, C</xref>
###xml 106 107 106 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 213 214 213 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 278 282 278 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 292 297 292 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B, C</xref>
###xml 362 367 362 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2V, W</xref>
###xml 737 741 737 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ogt </italic>
###xml 757 758 757 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
ogt morphants were smaller than controls and displayed a dramatic increase in apoptosis (Fig. 2B, C; Fig. 7). In addition, the morphants were deficient in endoderm and some mesoderm and ectoderm derivatives (Fig. 2). It is remarkable that we observe such strong phenotypes with ogt MOs (Fig. 2B, C) that reduced total O-GlcNAc modifications by only 20-35% (Fig. 2V, W). This raises the possibility that some Ogt targets may be more sensitive to reductions in O-GlcNAc than others. Furthermore, it suggests that additional roles for O-GlcNAc modifications could be uncovered if the amount of O-GlcNAc modifications were reduced to a greater extent, perhaps by co-injection of both MO1 and MO2. Given the dramatic increase in apoptosis in Ogt morphants (Fig. 7), however, it is possible that further reductions in O-GlcNAc levels would merely result in more dead or dying cells.
###end p 64
###begin p 65
###xml 196 197 196 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 348 349 348 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 975 977 975 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 62 71 <span type="species:ncbi:7955">zebrafish</span>
In a complementary approach, we overexpressed two variants of zebrafish Ogt. The resulting embryos were smaller than controls, and lacked endoderm and some ectoderm and mesoderm derivatives (Fig. 2). Cell counts revealed that Ogt overexpressing embryos had significantly fewer cells than controls, due to a concomitant increase in cell death (Fig. 7). Thus, embryonic development is severely disrupted by reducing O-GlcNAc levels by 20-35% as well as by increasing Ogt levels. This suggests that O-GlcNAc modifications must be maintained within a fairly narrow range for normal development. Surprisingly, decreasing O-GlcNAc levels produced the same range of defects as those observed in Ogt overexpressing embryos. This indicates that both the addition of O-GlcNAc to target proteins and its removal are essential for embryonic development. This is consistent with the idea that O-GlcNAc cycles on and off proteins, controlling a switch between two different active states [20].
###end p 65
###begin title 66
O-GlcNAc levels control the morphogenetic movements of epiboly
###end title 66
###begin p 67
###xml 130 134 130 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 227 231 227 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C&#8211;G</xref>
###xml 234 236 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 242 249 242 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 305 307 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 351 355 351 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 506 507 506 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9</xref>
###xml 509 511 509 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10</xref>
###xml 573 577 573 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
Our results indicate that gastrulation stage embryos are especially sensitive to changes in O-GlcNAc levels. First, we found that ogt expression decreases during gastrulation, consistent with the previous RT-PCR analysis (Fig. 1C-G) [46]. In Xenopus, Ogt protein levels also decrease during gastrulation [36]. This suggests that the downregulation of ogt during gastrulation has been conserved through evolution. In support of this conclusion, overexpression of Ogt or hOga causes a delay in epiboly (Fig. 9, 10 and data not shown). We did not observe delays in epiboly in ogt morphants, probably because these embryos continue expressing a significant amount of Ogt protein, as described above.
###end p 67
###begin p 68
###xml 198 200 198 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10</xref>
Control of morphogenetic movements represents a new role for O-GlcNAc modifications. To understand how O-GlcNAc might act during epiboly, we examined the MT and actin cytoskeleton in the yolk (Fig. 10). We found that the MT network in the cortical cytoplasm was disrupted in Ogt overexpressing embryos, with the MTs forming shortened, thickened filaments. The MT network is also disrupted in embryos overexpressing hOga. Similarly, the contractile actin ring in the YSL is absent in embryos overexpressing Ogt and hOga. We conclude that O-GlcNAc either directly or indirectly regulates that cytoskeletal network in the yolk.
###end p 68
###begin p 69
###xml 442 444 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B74">74</xref>
###xml 471 475 471 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spg </italic>
###xml 562 564 562 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B75">75</xref>
###xml 885 887 885 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B76">76</xref>
###xml 999 1001 999 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 318 323 <span type="species:ncbi:9606">human</span>
###xml 410 415 <span type="species:ncbi:9606">human</span>
###xml 427 436 <span type="species:ncbi:7955">zebrafish</span>
###xml 447 452 <span type="species:ncbi:10090">Mouse</span>
###xml 603 612 <span type="species:ncbi:7955">zebrafish</span>
The similarities between embryos overexpressing Ogt or hOga and those lacking the pou class transcription factor Spg/Pou5f1, suggest that Spg/Pou5f1 protein is a target of Ogt and that O-GlcNAc inactivates Spg/Pou5f1 protein. Consistent with this, we found that Pou5f1 protein immunoprecipitated from undifferentiated human ES cells is modified by O-GlcNAc. There is a high degree of sequence homology between human Pou5f1 and zebrafish Spg [74]. Mouse Pou5f1 can rescue spg mutants, indicating a high degree of functional conservation between the two proteins [75]. Therefore, it is highly likely that zebrafish Spg protein is also modified by Ogt. It is not known how O-GlcNAc modification regulates Pou5f1 function. Like many targets of Ogt, Pou5f1 is also modified by phosphorylation and the ability of Pou5f1 to stimulate transcription correlates with its phosphorylation status [76]. Depending upon which residues are modified, O-GlcNAc may stimulate or inhibit phosphorylation of Spg/Pou5f1 [20]. Further experiments are necessary to identify the residues modified by O-GlcNAc and to determine the functional consequences of O-GlcNAcylation on Spg/Pou5f1 protein.
###end p 69
###begin title 70
Conclusion
###end title 70
###begin p 71
###xml 291 295 291 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 536 541 <span type="species:ncbi:9606">human</span>
O-GlcNAc modifications are a poorly understood post-translational mechanism for regulating embryonic development. We demonstrated that embryonic O-GlcNAc levels control epiboly movements and cell survival, but do not regulate the initial cell fate decisions. Interestingly, gain and loss of ogt function produced the same range of defects. This indicates that the overall level of O-GlcNAc modification must be tightly controlled for normal embryonic development. Finally, O-GlcNAc modifies the pou class transcription factor Pou5f1 in human embryonic stem cells. Although the effect of this modification on Pou5f1 activity is not yet understood, it is possible that some of the defects described in this paper are mediated by improper regulation of Pou5f1.
###end p 71
###begin title 72
Methods
###end title 72
###begin title 73
###xml 0 9 <span type="species:ncbi:7955">Zebrafish</span>
Zebrafish strains, staging and imaging live embryos
###end title 73
###begin p 74
We obtained wild type embryos by natural mating of WIK adults. Embryonic stages were determined by morphology and are reported as hours post fertilization (hpf) at 28.5degreesC, according to Kimmel et al., 1995. Live embryos were mounted in 3% methylcellulose in depression slides, oriented appropriately and photographed under a Leica MZFLIII stereo dissecting microscope using bright field optics. For the time course, embryos were mounted at 2.5 hpf and stored on slides in wet chambers at 28.5degreesC. Images were obtained at regular intervals.
###end p 74
###begin title 75
Isolating clones encoding variant 2 and variant 4 Ogta
###end title 75
###begin p 76
###xml 207 209 207 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
We isolated a cDNA encoding the variant 2 isoform by PCR using a 15-19 hpf cDNA library as a template (gift from Bruce Appel, Vanderbilt University). Primers were designed from the full-length OGT sequence [46]. OGT full-length F: 5'-TTACGTCGACGAATGGCGAGCTCGGTG-3', OGT full-length R: 5'-ATGCGCGGCCGCGATCAGGTGCTCTCGC-3'. The PCR product was sequenced, and found to encode the variant 2 isoform. The cDNA was subcloned into the XbaI site of the pCS2 plasmid using the TOPO TA cloning kit (Invitrogen, Inc., Carlsbad, CA). To generate a cDNA encoding variant 4 OGT, we deleted exon 19 from variant 2 by long extension polymerase chain reaction (PCR) using primers flanking exon 19. OGTextF: 5'-TTTTTCTTAAGAAAAAGGCTGTTATTGACT-3'; OGTextR: 5'-AATTAGCTGGGTACCGGGCCCAATOGATTGGC-3'; exon19F: 5'-GCCACCACACAGATTAACAATAAA-3', exon19R: 5'-TTTTTCCCCCGCGGCCGCGAATTAAAAAACCTCCC-3'. To make the Ogt-GFP fusion protein using the Gateway system (Invitrogen, Inc., Carlsbad, CA), we amplified the N-terminal portion of Ogt using the following primers: BPogt1500F: 5'-GGGGACAAGTTTGTACAAAAAAGCAGGCTTAATGGCGAGCTCGGTGGGG-3'; BPogt1500R: 5'-GGGGACCACTTTGTACAAGAAAGCTGGGTAGCTGTGATGCGGATGCAC-3'. The resulting product was recombined into pDONR211. For the LR reaction, pDONRNogt was mixed with p3E-egfp and pCSDEST-2 and LR clonase following the manufacturers instructions.
###end p 76
###begin title 77
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
Phylogenetic analysis of ogt genes
###end title 77
###begin p 78
###xml 57 61 57 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 240 256 240 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Danio rerio ogt </italic>
###xml 336 357 336 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arabidopsis thaliana </italic>
###xml 389 402 389 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus </italic>
###xml 414 427 414 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Homo sapiens </italic>
###xml 439 457 439 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Takifugu rubripes </italic>
###xml 479 502 479 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tetraodon nigroviridis </italic>
###xml 523 546 523 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gasterosteus aculeatus </italic>
###xml 568 584 568 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Oryzias latipes </italic>
###xml 606 625 606 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona intestinalis </italic>
###xml 647 670 647 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Caenorhabditis elegans </italic>
###xml 240 251 <span type="species:ncbi:7955">Danio rerio</span>
###xml 336 356 <span type="species:ncbi:3702">Arabidopsis thaliana</span>
###xml 389 401 <span type="species:ncbi:10090">Mus musculus</span>
###xml 414 426 <span type="species:ncbi:9606">Homo sapiens</span>
###xml 439 456 <span type="species:ncbi:31033">Takifugu rubripes</span>
###xml 479 501 <span type="species:ncbi:99883">Tetraodon nigroviridis</span>
###xml 523 545 <span type="species:ncbi:69293">Gasterosteus aculeatus</span>
###xml 568 583 <span type="species:ncbi:8090">Oryzias latipes</span>
###xml 606 624 <span type="species:ncbi:7719">Ciona intestinalis</span>
###xml 647 669 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
ClustalW sequence alignment and phylogenetic analysis of ogt genes were performed on MacVector software. To construct the tree, we used the Neighbor joining method, and bootstrap values from 1000 replications are presented. We compared the Danio rerio ogt proteins (copy I: ENSDARP00000074945; copy II: ENSDARP00000054555), to those in Arabidopsis thaliana (SEC: NP187074; SPY: NP187761), Mus musculus (NP631883), Homo sapiens (AAH38180), Takifugu rubripes (ENSGACP00000024161), Tetraodon nigroviridis (GSTENP00017067001), Gasterosteus aculeatus (ENSTRUP00000024020), Oryzias latipes (ENSORLP00000007935), Ciona intestinalis (ENSCINP00000003035), Caenorhabditis elegans (NP001040861).
###end p 78
###begin title 79
###xml 12 20 12 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
Whole mount in situ hybridization
###end title 79
###begin p 80
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 61 63 61 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B77">77</xref>
###xml 114 115 114 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 116 118 116 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B78">78</xref>
###xml 119 121 119 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B81">81</xref>
in situ hybridization was performed as previously described [77]. We used the following probes described in Table 1[78-81].
###end p 80
###begin p 81
Marker genes used in this study.
###end p 81
###begin title 82
Microinjection of mRNA and MOs
###end title 82
###begin p 83
###xml 128 132 128 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 135 154 135 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;-galactosidase </italic>
###xml 170 175 167 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hOga </italic>
###xml 318 326 315 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
Sense mRNA was made using the Ambion mMessage mMachine RNA synthesis kit (Applied Biosystems, Austin TX). We injected 500 pg of ogt or beta-galactosidase mRNA, or 250 pg hOga mRNA into chorionated embryos at the 1-4 cell stage. Embryos were allowed to develop and examined at 24 hpf or fixed at appropriate stages for in situ hybridization.
###end p 83
###begin p 84
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 775 783 769 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 862 866 856 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
###xml 913 932 907 923 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;-galactosidase </italic>
###xml 940 944 931 935 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt </italic>
Translation blocking antisense morpholinos (MOs) to ogt transcripts were obtained from Gene Tools, Inc. (Philomath, OR). Their sequences are as follows: OGT MO1: 5'-CCACGTTCCCCACCGAGCTTGCCAT-3'; OGT MO2: 5'-TCTCCTTCACTCTTTACTGGATTCT-3'; OGT control (inverted): 5'-TCTTAGGTCATTTCTCACTTCCTCT-3'. To monitor efficiency of the injections, MO2 was tagged on the 3' with lissamine, and the inverted control was tagged at the 3' end with fluorescein. MOs were dissolved in distilled water at a concentration of 30 mg/ml and stored at -20degreesC. The working stock of each MO was diluted to 7.5 ng/nl in 0.2 M KCL prior to injection. Embryos were injected with 1 nl MO at the 1-4 cell stage. Embryos were allowed to develop and examined at 24 hpf or fixed at appropriate stages for in situ hybridization. For rescue experiments, embryos were injected first with 7.5 ng ogt MO, and subsequently injected with 10 or 50 pg beta-galactosidase mRNA or ogt mRNA.
###end p 84
###begin title 85
Flow cytometry and cell death assays
###end title 85
###begin p 86
###xml 130 149 130 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;-galactosidase </italic>
###xml 182 196 179 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt variant 4 </italic>
###xml 395 414 386 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;-galactosidase </italic>
###xml 491 506 479 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogta variant 4 </italic>
We used flow cytometry to count cells in control and Ogt overexpressing embryos. We injected embryos with either a combination of beta-galactosidase mRNA/FITC-conjugated dextran, or ogt variant 4 mRNA/AlexaFluor-647-conjugated dextran. Embryos were raised at 25degreesC until 18 hpf, when they were manually dechorionated. Prior to dissociation, we mixed an equal number normal embryos injected beta-galactosidase mRNA/FITC-conjugated dextran with Class I and Class II embryos injected with ogta variant 4 mRNA/AlexaFluor-647-conjugated dextran. The embryos were placed inside a nylon mesh basket that had been inserted into a 5 mm glass dish containing 10 ml PBS and 1% BSA, and ground with a plastic pestle. Dissociated cells were collected in plastic tubes and placed at 4degreesC. To concentrate the cells, we pelleted the cells by centrifugation at 2000 g for 10 min. The pellet was resuspended in 250 mul PBS, 1% BSA. The mixture of cells was analyzed in a LSR-II Analyzer (BD Biosciences) with BD FACSDiva 4.2 software. To detect cells containing FITC-dextran, the samples were excited by a sapphire blue laser at 488 nm, and the emission wavelength was detected with a 530 +/- 30 band-pass filter. To detect cells containing AlexaFluor-647-dextran, samples were excited with a HeNe laser at 633 nm, and the emission fluorescence was detected with a 660 +/-20 band-pass filter. Size gating was fixed by running 5 and 10 mum diameter standard beads. Cells from a small number of uninjected control embryos served as a control for autofluorescence. Gates for the respective fluorophores were established by running samples with only FITC positive cells or only AlexaFluor-647 positive cells.
###end p 86
###begin p 87
###xml 175 177 174 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B82">82</xref>
###xml 178 180 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B83">83</xref>
To assay for apoptosis, we dechorionated embryos on an agar-coated plate, and placed them in 5 mug/ml of acridine orange (Sigma Aldrich, St. Louis, MO) in embryo (E3) medium [82,83]. After 30 minutes, embryos were washed three times with embryo (E3) medium. The embryos were visualized using the FITC filter of a Leica MZFLIII fluorescent dissecting microscope (Leica Microsystems, Bannockburn, IL).
###end p 87
###begin title 88
Immunofluorescence and Confocal analysis of the cytoskeleton
###end title 88
###begin p 89
###xml 970 972 957 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B84">84</xref>
###xml 1151 1153 1132 1134 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 254 260 <span type="species:ncbi:9913">bovine</span>
###xml 1309 1314 <span type="species:ncbi:9940">sheep</span>
###xml 1581 1586 <span type="species:ncbi:10090">mouse</span>
At 8 hpf embryos were fixed with 4% paraformaldehyde in phosphate buffered saline (PBS) overnight at 4degreesC. Embryos were dechorionated and washed thoroughly with PBS containing 0.1% Tween (PBT). They were incubated in blocking solution containing 2% bovine serum albumin (BSA) at room temperature for 2 hours. To label F-Actin, embryos were incubated with rhodamine-phalloidin (Molecular Probes, Invitrogen, Inc., Carlsbad CA) at a dilution of 1:40 at room temperature in the dark. Embryos were washed 5 times in PBT, five minutes each wash. To make the stock solution, we dissolved rhodamine-phalloidin in methanol at a concentration of 6.6 muM and stored at -20degreesC. To analyze yolk MTs, embryos were manually dechorionated on agar-covered plates, and fixed at 4 hpf in Gard's Fixative for 4 hours at room temperature in small glass tubes [Gard's Fixative: 3.7% formaldehyde, 0.25% glutaraldehyde, 0.2% Triton X-100, 80 mM PIPES, pH 6.8, 5 mM EGTA, 1 mM MgCl2[84]]. They were washed once with PBS and stored overnight in 100% methanol at -20degreesC. The following day embryos were washed three times with PBS and incubated in 3.7 mg/ml NaBH4 for 6 hours at room temperature. The embryos were then washed 8 times in PBS and blocked for 1.5 hrs in blocking solution (1% DMSO, 0.5% Triton, 2% BSA, 2% sheep serum) and transferred to eppendorf tubes. Embryos were incubated in primary antibody (12G10 monoclonal anti alpha-tubulin antibody) at 1:100 dilution in block solution overnight. The following day, embryos were washed 3 times in PBS and incubated overnight in anti-mouse IgG-FITC (Zymed Laboratories) at a dilution of 1:200. Embryos were then washed with PBS and mounted and analyzed in a Leica TCS SP Confocal Microscope (Leica Microsystems, Bannockburn IL). Images were gathered in 10 mum sections and presented in Z-stacks.
###end p 89
###begin title 90
Bacterial expression of Ogt and enzymatic activity
###end title 90
###begin p 91
###xml 293 301 293 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 420 428 420 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 646 648 645 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 651 659 650 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 805 813 804 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 1576 1577 1574 1575 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 1611 1613 1609 1611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 293 305 <span type="species:ncbi:511693">E. coli BL21</span>
###xml 420 427 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
###xml 651 658 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
###xml 678 683 <span type="species:ncbi:9606">human</span>
###xml 805 812 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
Nucleotide sequences encoding variant 2 and variant 4 Ogt were cloned into pDONR (entry) and pDEST17 (expression) vectors via sequential recombination reactions according to manufacturer's instruction (Invitrogen, Carlsbad, CA). Expression plasmids containing the insert were transformed into E. coli BL21(DE3)pLysS competent cells (Stratagene, La Jolla, CA). To prepare bacterial lysate for activity assay, a colony of E. coli with each construct was culture in LB broth containing 100 mug/ml of ampicillin at room temperature at 250 rpm for 24 hours without induction. After harvesting, the cell pellets were processed as previously described [16]. E. coli strains containing human Oga and Ogt were also expressed in parallel for negative and positive controls respectively. To estimate the Ogt levels, E. coli lysates were resolved by precast 7.5% Tris-HCl precast minigel (Bio-Rad Laboratories, Hercules CA), and transferred to Immobilon-P transfer membrane (Millipore, Inc., Billerica, MA). After blocking with 3% BSA in TBS containing 0.1% Tween 20, the membrane was probed with HisProbe-HRP (1:1000 dilution, Thermo Scientific, Waltham, MA) and the final detection of HRP activity was performed using SuperSignal West Femto chemiluminescent substrate (Thermo Scientific, Waltham, MA) and exposed to CL-XPosure film (Thermo Scientific, Waltham, MA). Quantification of Ogt levels was done using Gel DocXR imager (Bio Rad Laboratories, Hercules CA). For enzymatic assay, 40 mug of crude lysate was added into reaction mixture containing a synthetic CKII peptide and UDP- [3H]GlcNAc as previously described [10] and allowed to react at 37degreesC for 35 min. The product was then purified via C18 column chromatography and the radioactive incorporation was measured by scintillation counter. The net incorporation of radioactive GlcNAc was subtracted by the reading of the negative control and normalizing the levels of Ogt before plotting.
###end p 91
###begin title 92
Immunoprecipitation of POU5F1 from hES cells
###end title 92
###begin p 93
###xml 827 829 820 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B85">85</xref>
###xml 77 82 <span type="species:ncbi:9606">human</span>
To prepare the nucleocytosolic fraction for immunoprecipitation, a pellet of human ES cells (BG02) was resuspended in 4 volumes of hypotonic buffer (5 mM Tris-HCl, pH 7.5/Protease inhibitor cocktail, Roche, Indianapolis, IN) and transferred into a 2 ml homogenizer. After incubating on ice for 10 min, the cell suspension was subjected to dounce homogenization followed by another 5 min incubation on ice. One volume of hypertonic buffer (0.1 M Tris-HCl, pH7.5, 2 M NaCl, 5 mM EDTA, 5 mM DTT/Protease inihibitor cocktail) was then added to the lysate. The lysate was incubated on ice for 5 min followed by another round of dounce homogenization. The resulting lysate was transferred to a microcentrifuge tube containing the Oga inhibitor PUGNAc (final concentration 10 muM) and centrifuged at 18,000 g for 25 min at 4degreesC [85]. The supernatant was transferred to new microcentrifuge tube. Protein concentration was determined using Bradford assay (Bio-Rad Laboratories, Hercules CA).
###end p 93
###begin p 94
###xml 147 153 <span type="species:ncbi:9986">rabbit</span>
###xml 367 371 <span type="species:ncbi:9925">goat</span>
To immunoprecipitate Pou5f1, 1 mg of nucleocytosolic fraction was supplemented with 1% NP-40 and 0.1% SDS, and precleared with a mixture of normal rabbit IgG AC and protein A/G PLUS agarose (Santa Cruz Biotechnology, Santa Cruz CA) at 4degreesC for 30 min. Following clarification, the precleared supernatant was incubated for 3 hours at 4degreesC in the presence of goat polyclonal antibody raised against an N-terminal Pou5f1 peptide (Santa Cruz Biotechnology, Santa Cruz CA) at a 1:200 dilution. 40 mul of protein A/G PLUS agarose slurry was then added into the IP sample and the mixture was incubated for another 2 hours at 4degreesC. After washing with 4 ml of IP wash buffer (10 mM Tris-HCl, pH7.5, 150 mM NaCl, 1% NP-40, 0.1% SDS), the IP complex was eluted by adding 50 mul of Laemmli sample buffer containing beta-mercaptoethanol and boiled at for 3 min. The sample was resolved by a 10% Tris-HCl precast minigel (Bio-Rad Laboratories, Hercules CA), and transferred to Immobilon-P transfer membrane (Millipore, Inc., Billerica, MA). After blocking with 3% BSA in TBS containing 0.1% Tween 20, the membrane was probed with RL-2 (1:1000 dilution) (Alexis Biochemicals, San Diego, CA). The final detection of HRP activity conjugated to the secondary antibodies was performed using SuperSignal West Femto chemiluminescent substrate (Thermo Scientific, Waltham, MA) and exposed to CL-XPosure film (Thermo Scientific, Waltham, MA). After developing the image on the film, the blot was then stripped with 0.1 M glycine (pH 2.5) at room temperature for 1 hour, wash with ddH2O and reprobed for Pou5f1 (1:1000 dilution) as described above.
###end p 94
###begin p 95
###xml 827 829 820 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B85">85</xref>
###xml 77 82 <span type="species:ncbi:9606">human</span>
To prepare the nucleocytosolic fraction for immunoprecipitation, a pellet of human ES cells (BG02) was resuspended in 4 volumes of hypotonic buffer (5 mM Tris-HCl, pH 7.5/Protease inhibitor cocktail, Roche, Indianapolis, IN) and transferred into a 2 ml homogenizer. After incubating on ice for 10 min, the cell suspension was subjected to dounce homogenization followed by another 5 min incubation on ice. One volume of hypertonic buffer (0.1 M Tris-HCl, pH7.5, 2 M NaCl, 5 mM EDTA, 5 mM DTT/Protease inihibitor cocktail) was then added to the lysate. The lysate was incubated on ice for 5 min followed by another round of dounce homogenization. The resulting lysate was transferred to a microcentrifuge tube containing the Oga inhibitor PUGNAc (final concentration 10 muM) and centrifuged at 18,000 g for 25 min at 4degreesC [85]. The supernatant was transferred to new microcentrifuge tube. Protein concentration was determined using Bradford assay (Bio-Rad Laboratories, Hercules CA).
###end p 95
###begin p 96
###xml 1575 1576 1552 1553 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 147 153 <span type="species:ncbi:9986">rabbit</span>
###xml 367 371 <span type="species:ncbi:9925">goat</span>
To immunoprecipitate Pou5f1, 1 mg of nucleocytosolic fraction was supplemented with 1% NP-40 and 0.1% SDS, and precleared with a mixture of normal rabbit IgG AC and protein A/G PLUS agarose (Santa Cruz Biotechnology, Santa Cruz CA) at 4degreesC for 30 min. Following clarification, the precleared supernatant was incubated for 3 hours at 4degreesC in the presence of goat polyclonal antibody raised against an N-terminal Pou5f1 peptide (Santa Cruz Biotechnology, Santa Cruz CA) at a 1:200 dilution. 40 mul of protein A/G PLUS agarose slurry was then added into the IP sample and the mixture was incubated for another 2 hours at 4degreesC. After washing with 4 ml of IP wash buffer (10 mM Tris-HCl, pH7.5, 150 mM NaCl, 1% NP-40, 0.1% SDS), the IP complex was eluted by adding 50 mul of Laemmli sample buffer containing beta-mercaptoethanol and boiled at for 3 min. The sample was resolved by a 10% Tris-HCl precast minigel (Bio-Rad Laboratories, Hercules CA), and transferred to Immobilon-P transfer membrane (Millipore, Inc., Billerica, MA). After blocking with 3% BSA in TBS containing 0.1% Tween 20, the membrane was probed with RL-2 (1:1000 dilution) (Alexis Biochemicals, San Diego, CA). The final detection of HRP activity conjugated to the secondary antibodies was performed using SuperSignal West Femto chemiluminescent substrate (Thermo Scientific, Waltham, MA) and exposed to CL-XPosure film (Thermo Scientific, Waltham, MA). After developing the image on the film, the blot was then stripped with 0.1 M glycine (pH 2.5) at room temperature for 1 hour, wash with ddH2O and reprobed for Pou5f1 (1:1000 dilution) as described above.
###end p 96
###begin title 97
Authors' contributions
###end title 97
###begin p 98
###xml 134 135 134 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 137 138 137 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 143 155 143 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10C, F, I, L</xref>
###xml 280 289 280 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 316 317 316 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 349 350 349 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 387 389 387 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11</xref>
###xml 600 601 600 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 672 684 672 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10C, F, I, L</xref>
###xml 844 852 844 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ogt-gfp </italic>
###xml 772 781 <span type="species:ncbi:7955">zebrafish</span>
###xml 1206 1215 <span type="species:ncbi:7955">zebrafish</span>
DMW participated in the design and performance of all experiments described in this paper, with the exceptions of those shown in Fig. 7, 3 and 10C, F, I, L. In addition, she wrote the first draft of the manuscript and aided in subsequent revisions. CFT designed and performed the in vitro glycosylation assays (Fig. 5), the RL2 Western Blot in Fig. 2, and the Pou5f1 IP experiment (Fig. 11). She wrote the corresponding sections in the Materials and Methods sections. YS designed and performed the flow cytometry experiments with the assistance of KDK, and performed the acridine orange stains (Fig. 7). YS performed the confocal analysis of hOga expressing embryos (Fig. 10C, F, I, L) with the assistance of DW. DW designed the protocol we used to visualize MTs in early zebrafish embryos, and assisted with the confocal analysis. SG made the ogt-gfp fusion construct and assisted with the injections to test the efficiency of ogt-MOs. LW provided expertise on O-GlcNAc and supervised the design, execution and interpretation of the biochemical experiments. STD conceived of the project and designed the experimental plan. He also supervised the design, execution and interpretation of all experiments in zebrafish embryos. After the first draft, STD revised the manuscript with the assistance of DMW, CFT, and LW. All authors have read and approved the final manuscript.
###end p 98
###begin title 99
Acknowledgements
###end title 99
###begin p 100
###xml 179 187 179 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 1218 1223 <span type="species:ncbi:9606">human</span>
The authors would like to thank Drs. Lilianna Solnica-Krezel, Marcus Fechheimer, and Jim Lauderdale for helpful advice and discussions; C. Sias for assistance with injections and in situ hybridizations; Rebecca Ball, Chari Jefferson, Tabitha West, Sarita Pathak and Dayne Turner for fish care. We are grateful to Joseph Frankel for 12G10 antibody (available from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by the University of Iowa), and to Dr. Steven Dalton for providing the Pou5f1 polyclonal antibody. We are also grateful to the Chien Lab (University of Utah Medical Center, Salt Lake City, UT) and the Lawson Lab (University of Massachussetts Medical School, Worcester, MA) for generating the initial plasmids used for our Gateway cloning. Work in the Dougan laboratory is funded by a grant from the American Cancer Society (ACS RSG DDC-112979). Work in the Wells laboratory is funded in part by a grant from NIDDK/NIH (1R01DK075069). S. T. D. and L. W. are Georgia Cancer Coalition Distinguished Investigators. C. F. T. is an American Heart Association pre-doctoral fellow. In accordance with ACS policy, ACS funds were not used to support experiments with human embryonic stem cells.
###end p 100
###begin article-title 101
Modulation of O-GlcNAc glycosylation during Xenopus oocyte maturation
###end article-title 101
###begin article-title 102
Glycosylation of the c-Myc transactivation domain
###end article-title 102
###begin article-title 103
Glucose mediates the translocation of NeuroD1 by O-linked glycosylation
###end article-title 103
###begin article-title 104
Stabilization of plakoglobin and enhanced keratinocyte cell-cell adhesion by intracellular O-glycosylation
###end article-title 104
###begin article-title 105
Cytoplasmic O-glycosylation prevents cell surface transport of E-cadherin during apoptosis
###end article-title 105
###begin article-title 106
Nuclear pore complex contains a family of glycoproteins that includes p62: glycosylation through a previously unidentified cellular pathway
###end article-title 106
###begin article-title 107
O-glycosylation of eukaryotic transcription factors: implications for mechanisms of transcriptional regulation
###end article-title 107
###begin article-title 108
RNA polymerase II is a glycoprotein. Modification of the COOH-terminal domain by O-GlcNAc
###end article-title 108
###begin article-title 109
High molecular weight microtubule-associated proteins contain O-linked-N-acetylglucosamine
###end article-title 109
###begin article-title 110
The microtubule-associated protein tau is extensively modified with O-linked N-acetylglucosamine
###end article-title 110
###begin article-title 111
###xml 40 45 <span type="species:ncbi:4565">wheat</span>
Glycosylation of RNA polymerase II from wheat germ
###end article-title 111
###begin article-title 112
O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability
###end article-title 112
###begin article-title 113
Recruitment of O-GlcNAc transferase to promoters by corepressor mSin3A: coupling protein O-GlcNAcylation to transcriptional repression
###end article-title 113
###begin article-title 114
Identification and cloning of a novel family of coiled-coil domain proteins that interact with O-GlcNAc transferase
###end article-title 114
###begin article-title 115
Recombinant O-GlcNAc transferase isoforms: identification of O-GlcNAcase, yes tyrosine kinase, and tau as isoform-specific substrates
###end article-title 115
###begin article-title 116
Perturbations in O-linked beta-N-acetylglucosamine protein modification cause severe defects in mitotic progression and cytokinesis
###end article-title 116
###begin article-title 117
Reduced O glycosylation of Sp1 is associated with increased proteasome susceptibility
###end article-title 117
###begin article-title 118
Insulin stimulates and diabetes inhibits O-linked N-acetylglucosamine transferase and O-glycosylation of Sp1
###end article-title 118
###begin article-title 119
Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc
###end article-title 119
###begin article-title 120
Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins
###end article-title 120
###begin article-title 121
Glycosylation of nuclear and cytoplasmic proteins. Purification and characterization of a uridine diphospho-N-acetylglucosamine:polypeptide beta-N-acetylglucosaminyltransferase
###end article-title 121
###begin article-title 122
Dynamic glycosylation of nuclear and cytosolic proteins. Cloning and characterization of a unique O-GlcNAc transferase with multiple tetratricopeptide repeats
###end article-title 122
###begin article-title 123
###xml 146 151 <span type="species:ncbi:9606">human</span>
Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain
###end article-title 123
###begin article-title 124
Dynamic O-glycosylation of nuclear and cytosolic proteins: further characterization of the nucleocytoplasmic beta-N-acetylglucosaminidase, O-GlcNAcase
###end article-title 124
###begin article-title 125
O-linked N-acetylglucosamine: the "yin-yang" of Ser/Thr phosphorylation? Nuclear and cytoplasmic glycosylation
###end article-title 125
###begin article-title 126
The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector
###end article-title 126
###begin article-title 127
Hepatic glucose sensing via the CREB coactivator CRTC2
###end article-title 127
###begin article-title 128
The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism
###end article-title 128
###begin article-title 129
Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance
###end article-title 129
###begin article-title 130
Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes
###end article-title 130
###begin article-title 131
Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia
###end article-title 131
###begin article-title 132
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human O-GlcNAc transferase (OGT): genomic structure, analysis of splice variants, fine mapping in Xq13.1
###end article-title 132
###begin article-title 133
Mitochondrial and nucleocytoplasmic targeting of O-linked GlcNAc transferase
###end article-title 133
###begin article-title 134
Regulation of a cytosolic and nuclear O-GlcNAc transferase. Role of the tetratricopeptide repeats
###end article-title 134
###begin article-title 135
Mutational analysis of the catalytic domain of O-linked N-acetylglucosaminyl transferase
###end article-title 135
###begin article-title 136
Microinjection of recombinant O-GlcNAc transferase potentiates Xenopus oocytes M-phase entry
###end article-title 136
###begin article-title 137
Structure of an O-GlcNAc transferase homolog provides insight into intracellular glycosylation
###end article-title 137
###begin article-title 138
###xml 113 118 <span type="species:ncbi:10090">mouse</span>
The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny
###end article-title 138
###begin article-title 139
Ogt-dependent X-chromosome-linked protein glycosylation is a requisite modification in somatic cell function and embryo viability
###end article-title 139
###begin article-title 140
###xml 80 94 <span type="species:ncbi:8355">Xenopus laevis</span>
O-linked N-acetylglucosaminyltransferase inhibition prevents G2/M transition in Xenopus laevis oocytes
###end article-title 140
###begin article-title 141
###xml 29 42 <span type="species:ncbi:4932">Saccharomyces</span>
Genetic and physical maps of Saccharomyces cerevicea
###end article-title 141
###begin article-title 142
###xml 54 74 <span type="species:ncbi:3702">Arabidopsis thaliana</span>
Two O-linked N-acetylglucosamine transferase genes of Arabidopsis thaliana L. Heynh. have overlapping functions necessary for gamete and seed development
###end article-title 142
###begin article-title 143
###xml 70 90 <span type="species:ncbi:3702">Arabidopsis thaliana</span>
SECRET AGENT and SPINDLY have overlapping roles in the development of Arabidopsis thaliana L. Heyn
###end article-title 143
###begin article-title 144
SPINDLY, a tetratricopeptide repeat protein involved in gibberellin signal transduction in Arabidopsis
###end article-title 144
###begin article-title 145
Altered expression of SPINDLY affects gibberellin response and plant development
###end article-title 145
###begin article-title 146
###xml 59 68 <span type="species:ncbi:7955">zebrafish</span>
Transcriptional regulation and O-GlcNAcylation activity of zebrafish OGT during embryogenesis
###end article-title 146
###begin article-title 147
###xml 20 38 <span type="species:ncbi:7719">Ciona intestinalis</span>
The draft genome of Ciona intestinalis: insights into chordate and vertebrate origins
###end article-title 147
###begin article-title 148
###xml 2 24 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
A Caenorhabditis elegans model of insulin resistance: altered macronutrient storage and dauer formation in an OGT-1 knockout
###end article-title 148
###begin article-title 149
Evolution and diversity of fish genomes
###end article-title 149
###begin article-title 150
###xml 26 38 <span type="species:ncbi:70862">teleost fish</span>
###xml 39 61 <span type="species:ncbi:99883">Tetraodon nigroviridis</span>
Genome duplication in the teleost fish Tetraodon nigroviridis reveals the early vertebrate proto-karyotype
###end article-title 150
###begin article-title 151
###xml 60 73 <span type="species:ncbi:31033">Fugu rubripes</span>
Whole-genome shotgun assembly and analysis of the genome of Fugu rubripes
###end article-title 151
###begin article-title 152
Ensembl 2007
###end article-title 152
###begin article-title 153
###xml 31 40 <span type="species:ncbi:7955">zebrafish</span>
Differential expression of two zebrafish emx homeoprotein mRNAs in the developing brain
###end article-title 153
###begin article-title 154
floating head and masterblind regulate neuronal patterning in the roof of the forebrain
###end article-title 154
###begin article-title 155
###xml 15 24 <span type="species:ncbi:7955">zebrafish</span>
Cloning of the zebrafish krox-20 gene (krx-20) and its expression during hindbrain development
###end article-title 155
###begin article-title 156
###xml 25 34 <span type="species:ncbi:7955">zebrafish</span>
Specific localization of zebrafish hsp90 alpha mRNA to myoD-expressing cells suggests a role for hsp90 alpha during normal muscle development
###end article-title 156
###begin article-title 157
###xml 53 62 <span type="species:ncbi:7955">zebrafish</span>
A molecular pathway leading to endoderm formation in zebrafish
###end article-title 157
###begin article-title 158
###xml 46 55 <span type="species:ncbi:7955">zebrafish</span>
Origin and shaping of the laterality organ in zebrafish
###end article-title 158
###begin article-title 159
###xml 14 23 <span type="species:ncbi:7955">zebrafish</span>
Expression of zebrafish goosecoid and no tail gene products in wild- type and mutant no tail embryos
###end article-title 159
###begin article-title 160
###xml 69 78 <span type="species:ncbi:7955">zebrafish</span>
Goosecoid expression in neurectoderm and mesendoderm is disrupted in zebrafish cyclops gastrulas
###end article-title 160
###begin article-title 161
###xml 121 130 <span type="species:ncbi:7955">zebrafish</span>
Mezzo, a paired-like homeobox protein is an immediate target of Nodal signalling and regulates endoderm specification in zebrafish
###end article-title 161
###begin article-title 162
###xml 22 31 <span type="species:ncbi:7955">zebrafish</span>
Expression pattern of zebrafish pax genes suggests a role in early brain regionalization
###end article-title 162
###begin article-title 163
###xml 16 25 <span type="species:ncbi:7955">zebrafish</span>
Expression of a zebrafish cathepsin L gene in anterior mesendoderm and hatching gland
###end article-title 163
###begin article-title 164
###xml 28 37 <span type="species:ncbi:7955">zebrafish</span>
Developmental regulation of zebrafish MyoD in wild-type, no tail and spadetail embryos
###end article-title 164
###begin article-title 165
###xml 50 59 <span type="species:ncbi:7955">zebrafish</span>
Cell movements during epiboly and gastrulation in zebrafish
###end article-title 165
###begin article-title 166
###xml 43 52 <span type="species:ncbi:7955">zebrafish</span>
Ultraviolet irradiation impairs epiboly in zebrafish embryos: evidence for a microtubule-dependent mechanism of epiboly
###end article-title 166
###begin article-title 167
###xml 26 35 <span type="species:ncbi:7955">zebrafish</span>
Microtubule arrays of the zebrafish yolk cell: organization and function during epiboly
###end article-title 167
###begin article-title 168
###xml 67 76 <span type="species:ncbi:7955">zebrafish</span>
Organization and function of microfilaments during late epiboly in zebrafish embryos
###end article-title 168
###begin article-title 169
Polyglycylation domain of beta-tubulin maintains axonemal architecture and affects cytokinesis in Tetrahymena
###end article-title 169
###begin article-title 170
###xml 72 81 <span type="species:ncbi:7955">zebrafish</span>
Cell adhesion and the actin cytoskeleton of the enveloping layer in the zebrafish embryo during epiboly
###end article-title 170
###begin article-title 171
###xml 130 139 <span type="species:ncbi:7955">zebrafish</span>
Alterations of the cytoskeleton in all three embryonic lineages contribute to the epiboly defect of Pou5f1/Pou5f1 deficient MZspg zebrafish embryos
###end article-title 171
###begin article-title 172
Maternal control of vertebrate dorsoventral axis formation and epiboly by the POU domain protein Spg/Pou2/Pou5f1
###end article-title 172
###begin article-title 173
The POU domain protein spg (pou2/Pou5f1) is essential for endoderm formation in cooperation with the HMG domain protein casanova
###end article-title 173
###begin article-title 174
###xml 4 13 <span type="species:ncbi:7955">zebrafish</span>
The zebrafish spiel-ohne-grenzen (spg) gene encodes the POU domain protein Pou2 related to mammalian Pou5f1 and is essential for formation of the midbrain and hindbrain, and for pre-gastrula morphogenesis
###end article-title 174
###begin article-title 175
###xml 79 88 <span type="species:ncbi:7955">zebrafish</span>
Spiel-ohne-grenzen/pou2 mediates regional competence to respond to Fgf8 during zebrafish early neural development
###end article-title 175
###begin article-title 176
The carboxy-terminal transactivation domain of Oct-4 acquires cell specificity through the POU domain
###end article-title 176
###begin article-title 177
###xml 75 84 <span type="species:ncbi:7955">zebrafish</span>
Time-dependent patterning of the mesoderm and endoderm by Nodal signals in zebrafish
###end article-title 177
###begin article-title 178
###xml 105 114 <span type="species:ncbi:7955">zebrafish</span>
Lithium perturbation and goosecoid expression identify a dorsal specification pathway in the pregastrula zebrafish
###end article-title 178
###begin article-title 179
###xml 30 39 <span type="species:ncbi:7955">zebrafish</span>
A homeobox gene essential for zebrafish notochord development
###end article-title 179
###begin article-title 180
###xml 21 30 <span type="species:ncbi:7955">zebrafish</span>
###xml 48 53 <span type="species:ncbi:10090">mouse</span>
no tail (ntl) is the zebrafish homologue of the mouse T (Brachyury) gene
###end article-title 180
###begin article-title 181
###xml 40 50 <span type="species:ncbi:7227">Drosophila</span>
###xml 128 137 <span type="species:ncbi:7955">zebrafish</span>
A functionally conserved homolog of the Drosophila segment polarity gene hh is expressed in tissues with polarizing activity in zebrafish embryos
###end article-title 181
###begin article-title 182
###xml 29 39 <span type="species:ncbi:7227">Drosophila</span>
Programmed cell death during Drosophila embryogenesis
###end article-title 182
###begin article-title 183
###xml 75 84 <span type="species:ncbi:7955">zebrafish</span>
A rapid apoptosis assay measuring relative acridine orange fluorescence in zebrafish embryos
###end article-title 183
###begin article-title 184
###xml 61 75 <span type="species:ncbi:8355">Xenopus laevis</span>
Organization, nucleation, and acetylation of microtubules in Xenopus laevis oocytes: a study by confocal immunofluorescence microscopy
###end article-title 184
###begin article-title 185
Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-beta-N-acetylglucosaminidase inhibitor O-(2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate
###end article-title 185
###begin article-title 186
p53 activation by knockdown technologies
###end article-title 186

